Presumptive Service Connection for Bladder, Ureter, and Related Genitourinary Cancers Due to Exposure to Fine Particulate Matter, 23-30 [2024-31220]
Download as PDF
Federal Register / Vol. 90, No. 1 / Thursday, January 2, 2025 / Rules and Regulations
(f) Compliance
Comply with this AD within the
compliance times specified, unless already
done.
(g) Requirements
Except as specified in paragraph (h) of this
AD: Comply with all required actions and
compliance times specified in, and in
accordance with European Union Aviation
Safety Agency Emergency AD 2024–0206–E,
dated October 22, 2024 (EASA AD 2024–
0206–E).
(h) Exceptions to EASA AD 2024–0206–E
(1) Where EASA AD 2024–0206–E requires
compliance in terms of flight hours, this AD
requires using hours time-in-service.
(2) Where EASA AD 2024–0206–E refers to
its effective date, this AD requires using the
effective date of this AD.
(3) Paragraph (5) EASA AD 2024–0206–E
specifies to report inspection results to AH
[Airbus Helicopters] within certain
compliance times. For this AD, report
inspection results at the applicable times
specified in paragraph (h)(3)(i) or (ii) of this
AD.
(i) For an inspection done on or after the
effective date of this AD: Submit the report
within 7 days after the inspection.
(ii) For an inspection done before the
effective date of this AD: Submit the report
within 7 days after the effective date of this
AD.
(4) This AD does not adopt the ‘‘Remarks’’
section of EASA AD 2024–0206–E.
(j) Alternative Methods of Compliance
(AMOCs)
(1) The Manager, International Validation
Branch, FAA, has the authority to approve
AMOCs for this AD, if requested using the
procedures found in 14 CFR 39.19. In
accordance with 14 CFR 39.19, send your
request to your principal inspector or local
Flight Standards District Office, as
appropriate. If sending information directly
to the manager of the International Validation
Branch, send it to the attention of the person
identified in paragraph (k) of this AD and
email to: AMOC@faa.gov.
(2) Before using any approved AMOC,
notify your appropriate principal inspector,
or lacking a principal inspector, the manager
of the local flight standards district office/
certificate holding district office.
ddrumheller on DSK120RN23PROD with RULES1
(k) Additional Information
For more information about this AD,
contact Michael Mueller, Aviation Safety
Engineer, FAA, 1600 Stewart Avenue, Suite
410, Westbury, NY 11590; phone: (847) 294–
7543; email: Michael.J.Mueller@faa.gov.
(l) Material Incorporated by Reference
(1) The Director of the Federal Register
approved the incorporation by reference of
the material listed in this paragraph under 5
U.S.C. 552(a) and 1 CFR part 51.
(2) You must use this material as
applicable to do the actions required by this
AD, unless the AD specifies otherwise.
16:04 Dec 31, 2024
Jkt 265001
Issued on December 17, 2024.
Victor Wicklund,
Deputy Director, Compliance & Airworthiness
Division, Aircraft Certification Service.
[FR Doc. 2024–31510 Filed 12–30–24; 11:15 am]
BILLING CODE 4910–13–P
DEPARTMENT OF VETERANS
AFFAIRS
38 CFR Part 3
2900–AS21
(i) Special Flight Permits
Special flight permits are prohibited.
VerDate Sep<11>2014
(i) European Union Aviation Safety Agency
(EASA) Emergency AD 2024–0206–E, dated
October 22, 2024.
(ii) [Reserved]
(3) For EASA material identified in this
AD, contact EASA, Konrad-Adenauer-Ufer 3,
50668 Cologne, Germany; phone: +49 221
8999 000; email: ADs@easa.europa.eu;
website: easa.europa.eu. You may find the
EASA material on the EASA website at
ad.easa.europa.eu.
(4) You may view this material at the FAA,
Office of the Regional Counsel, Southwest
Region, 10101 Hillwood Parkway, Room 6N–
321, Fort Worth, TX 76177. For information
on the availability of this material at the
FAA, call (817) 222–5110.
(5) You may view this material at the
National Archives and Records
Administration (NARA). For information on
the availability of this material at NARA,
visit www.archives.gov/federal-register/cfr/
ibr-locations or email fr.inspection@nara.gov.
Presumptive Service Connection for
Bladder, Ureter, and Related
Genitourinary Cancers Due to
Exposure to Fine Particulate Matter
Department of Veterans Affairs.
Interim final rule.
AGENCY:
ACTION:
The Department of Veterans
Affairs (VA) is issuing this interim final
rule (IFR) to amend its adjudication
regulations to establish presumptive
service connection for urinary bladder,
ureter, and related genitourinary (GU)
cancers due to exposure to Particulate
Matter 2.5 (PM2.5) and to implement
certain provisions of the Sergeant First
Class Heath Robinson Honoring our
Promise to Address Comprehensive
Toxics Act of 2022 (PACT Act). The
new presumptions would apply to
Veterans who served on active military,
naval, air, or space service in Southwest
Asia theater of operations or Somalia
during the Persian Gulf War (hereafter
Gulf War) on or after August 2, 1990,
and in Afghanistan, Syria, Djibouti,
Uzbekistan, Egypt, Jordan, Lebanon, and
Yemen during the Gulf War on or after
September 11, 2001. This amendment is
necessary to provide expeditious health
care, services, and benefits to these
veterans. This IFR addresses the needs
SUMMARY:
PO 00000
Frm 00023
Fmt 4700
Sfmt 4700
23
and concerns of Gulf War veterans and
Service members who have served and
continue to serve in these locations and
have been diagnosed with bladder,
ureter, and related GU cancers. Neither
Congress nor the President has
established an end date for the Gulf
War. Therefore, to expedite the
provision of health care, services, and
benefits to current and future Gulf War
veterans who may be affected by PM2.5
due to their military service, VA is
establishing presumptive service
connection for urinary bladder, ureter,
and related GU cancers. This IFR will
ease the evidentiary burden of Gulf War
Veterans who file claims with VA for
these conditions.
DATES:
Effective date: This interim final rule
is effective January 2, 2025.
Comment date: Comments must be
received on or before March 3, 2025.
ADDRESSES: Comments must be
submitted through www.regulations.gov.
Except as provided below, comments
received before the close of the
comment period will be available at
www.regulations.gov for public viewing,
inspection, or copying, including any
personally identifiable or confidential
business information that is included in
a comment. We post the comments
received before the close of the
comment period on
www.regulations.gov as soon as possible
after they have been received. VA will
not post on Regulations.gov public
comments that make threats to
individuals or institutions or suggest
that the commenter will take actions to
harm an individual. VA encourages
individuals not to submit duplicative
comments; however, we will post
comments from multiple unique
commenters even if the content is
identical or nearly identical to other
comments. Any public comment
received after the comment period’s
closing date is considered late and will
not be considered in the final
rulemaking. In accordance with the
Providing Accountability Through
Transparency Act of 2023, a plain
language summary (not more than 100
words in length) of this interim final
rule is available at www.regulations.gov,
under RIN 2900–AS21.
FOR FURTHER INFORMATION CONTACT: Sara
Cohen, Lead, Part 3 Regulations Staff,
Robert Parks, Chief, Part 3 Regulations
Staff (211C), Compensation Service
(21C), Veterans Benefits Administration,
Department of Veterans Affairs, 810
Vermont Avenue NW, Washington, DC
20420, (202) 461–9700. (This is not a
toll-free telephone number.)
SUPPLEMENTARY INFORMATION:
E:\FR\FM\02JAR1.SGM
02JAR1
ddrumheller on DSK120RN23PROD with RULES1
24
Federal Register / Vol. 90, No. 1 / Thursday, January 2, 2025 / Rules and Regulations
I. Background
On August 10, 2022, Congress enacted
Public Law 117–168, the PACT Act. The
PACT Act provided a process for VA to
establish presumptive service
connection based on toxic exposures. 38
U.S.C. 1171 et seq. The PACT Act also
added a presumption of service
connection for certain diseases
associated with exposure to burn pits
and other toxins (BPOT) in 38 U.S.C.
1120. This presumption applies to
veterans who served in locations listed
in 38 U.S.C. 1119(c)(1). The diseases
subject to the presumption include
kidney cancers and ‘‘[r]eproductive
cancer of any type.’’ 38 U.S.C.
1120(b)(2)(E), (G). Kidney and
reproductive cancers are part of
genitourinary (GU) tract. Although the
GU system is composed of kidneys,
ureters, urinary bladder, urethra,1
reproductive and genital organs,
including the ureteric orifice, urachus,
and over-lapping sites of the bladder
(the urinary organs), the PACT Act did
not address all these organs.
Following the 38 U.S.C. 1171 et seq.
process, VA determined it was
necessary and clinically appropriate to
consider expanding presumptive status
consideration to cancers of these
additional organs. One of VA’s priorities
is to address the long overdue needs of
the Gulf War cohort and to address the
imminent need for these veterans to
receive care, services, and benefits. VA
has reviewed both medical and
scientific literature, and concludes that
(1) urinary bladder cancer is sufficiently
linked to PM2.5 and that (2) cancers of
the ureter, ureteric orifice, urachus, and
over-lapping sites of the bladder are
closely related to urinary bladder cancer
with a common embryologic,
anatomical, structural, and functional
relationship. Moreover, the cancers of
the ureter, ureteric orifice, urachus, and
over-lapping sites of the bladder are
exposed to toxic waste from the kidneys
and the bladder as part of the GU
system’s function. Because, as discussed
below, there is a medical nexus between
the composition and duration of PM2.5
and airborne hazard exposures to the
development of GU cancers, VA has
determined that presumptions of service
connection for these cancers are
warranted. See 38 U.S.C. 1174(a)(1).
In this IFR, VA adds 38 CFR 3.320a
to its adjudicatory regulations to
presume service connection for these
1 VA does not address urethral cancer in this
rulemaking, because such cancer is a reproductive
cancer, and therefore already subject to
presumptive service connection under 38 U.S.C.
1120(b)(2)(E). See 89 FR 79815, 79824 (2024)
(proposed rule).
VerDate Sep<11>2014
16:04 Dec 31, 2024
Jkt 265001
cancers for certain Gulf War Veterans.
VA adds these cancers as presumptive
in 38 CFR 3.320a by IFR so that any
Veteran with these cancers and who
served in a prescribed location need not
wait for benefits.
II. Scientific Background
a. Exposure to Fine Particulate Matter
On August 5, 2021, VA promulgated
38 CFR 3.320 to establish presumptions
of service connection for certain chronic
diseases based on exposure to PM2.5
during service in the Southwest Asia
theater of operations during the Persian
Gulf War, or service in Afghanistan,
Syria, Djibouti, or Uzbekistan, on or
after September 19, 2001, during the
Persian Gulf War. 86 FR 42724, 42733
(2021) (interim final rule); see 88 FR
60341 (2023) (adopting the interim final
rule with changes). VA based these
presumptions on review and analysis of
airborne hazards in the Southwest Asia
theater of operations during the Persian
Gulf War, by examining the National
Academies of Science, Engineering, and
Medicine’s (NASEM) 2020 report,
Respiratory Health Effects of Airborne
Hazards Exposures in the Southwest
Asia Theater of Military Operations; 2
NASEM’s 2011 report, Long-Term
Health Consequences of Exposure to
Burn Pits in Iraq and Afghanistan; 3 and
NASEM’s 2010 report, Review of the
Department of Defense (DoD) Enhanced
Particulate Matter Surveillance
Program.4 See 86 FR at 42725–42726.
The 2010 report concluded that Service
members deployed to the Middle East
‘‘are exposed to high concentrations of
PM[2.5].’’ 5 See 86 FR at 42725. Toxic
compounds present in burn pit fumes
include PM2.5.6 This airborne pollution
includes smoke from oil well fires, sand,
dust, mechanical fumes from aircraft,
vehicle, and ship engines, wood, plastic,
rubber, metals, munitions, chemicals,
2 National Academies of Sciences, Engineering,
and Medicine 2020. Respiratory Health Effects of
Airborne Hazards Exposures in the Southwest Asia
Theater of Military Operations. Washington, DC:
The National Academies Press. https://doi.org/
10.17226/25837.
3 Institute of Medicine 2011. Long-Term Health
Consequences of Exposure to Burn Pits in Iraq and
Afghanistan. Washington, DC: The National
Academies Press. https://doi.org/10.17226/13209
(hereinafter ‘‘NASEM 2011 Report’’).
4 National Research Council 2010. Review of the
Department of Defense Enhanced Particulate Matter
Surveillance Program Report. Washington, DC: The
National Academies Press. https://doi.org/
10.17226/12911 (hereinafter ‘‘NRC’’).
5 NRC, supra.
6 Wang X, Doherty TA, James C. Military burn pit
exposure and airway disease: Implications for our
Veteran population. Ann Allergy Asthma Immunol.
2023 Dec;131(6):720–725. doi: 10.1016/
j.anai.2023.06.012. https://pmc.ncbi.nlm.nih.gov/
articles/PMC10728339/.
PO 00000
Frm 00024
Fmt 4700
Sfmt 4700
and food and human waste.7 Incomplete
combustion of organic and inorganic
material in burn pits results in high
volumes of toxic PM in the air that
includes metals, benzene, and other
toxic compounds.8
When promulgating 38 CFR 3.320 in
August 2021, to determine the
qualifying periods of service, VA
primarily considered (1) whether burn
pits were used in the location, (2) the
PM2.5 levels, and (3) desert climates
according to 86 FR at 42725–42729.
However, in August 2022, the PACT Act
created new 38 U.S.C. 1119,
‘‘Presumptions of toxic exposure,’’ with
a different list of qualifying periods of
service. Section 1119(c) defines a
‘‘covered veteran’’ as a veteran who
served in the following eligible
locations: Bahrain, Iraq, Kuwait, Oman,
Qatar, Saudi Arabia, Somalia, and the
United Arab Emirates, on or after
August 2, 1990, and Afghanistan,
Djibouti, Egypt, Jordan, Lebanon, Syria,
Yemen, and Uzbekistan on or after
September 11, 2001.
In the present rulemaking, after
reviewing the three considerations of
burn pit use, PM2.5 levels, and desert
climates, VA has determined that the
qualifying periods of service should
include both those listed in 38 CFR
3.320(a)(5) and those listed in 38 U.S.C.
1119(c) to ensure that (1) veterans
currently eligible for the presumption of
exposure to PM2.5 in 38 CFR 3.320 and
(2) veterans eligible for the presumption
of exposure to BPOT in 38 U.S.C. 1119
are both covered in this rulemaking.
Thus, VA’s new presumptions in 38
CFR 3.320a will not simply cover the
locations in current 38 CFR 3.320(a)(5),
but also the locations listed in 38 U.S.C.
1119(c) (including Egypt, Jordan,
Lebanon, Somalia, and Yemen).
This approach conforms with the
information available regarding
documented burn pit use. In 2021, DoD
provided Congress with a list of
locations within U.S. Central Command
where open burn pits have been used
since 2001.9 The U.S. Central
Command’s Area of Responsibility
consists of 21 nations that stretch from
Northeast Africa across the Middle East
to Central and South Asia 10 and is the
only combatant command that conducts
7 Id.
8 American Cancer Society. Military Burn Pits
and Cancer Risk. 2022. https://www.cancer.org/
healthy/cancer-causes/chemicals/burn-pits.html.
9 See Letter from Office of Under Secretary of
Defense to the U.S. House of Representatives
Committee on Appropriations (May 7, 2001),
available on the rulemaking docket at
www.regulations.gov (hereinafter ‘‘Defense Letter’’).
10 U.S. Central Command. Area of Responsibility.
https://www.centcom.mil/AREA-OFRESPONSIBILITY/.
E:\FR\FM\02JAR1.SGM
02JAR1
Federal Register / Vol. 90, No. 1 / Thursday, January 2, 2025 / Rules and Regulations
ddrumheller on DSK120RN23PROD with RULES1
open burn pit operations.11 Egypt,
Jordan, Lebanon, and Yemen were
included as locations with open, active
burn pits.12 Somalia was not included
on the list. However, there is evidence
of burn pit use in Somalia when service
members were deployed in support of
Operation Show Care in 1993.13
Additional deployments occurred in
1992, 1995, 2012, and 2022.14
Additionally, all the locations listed
in 38 U.S.C. 1119(c) have similar arid
desert climate conditions. DoD’s 2008
Enhanced Particulate Matter
Surveillance Program studied the
chemical and physical properties of
dust at 15 deployment sites in the
Middle East, Central Asia, and
Northeast Africa.15 The study found that
Military Exposure Guideline (MEG)
values for PM2.5 were exceeded at all 15
sites for the entire one-year sampling
period.16 The study also demonstrated
how short-term dust events—
exacerbated by dirt roads, agricultural
activities, and disturbance of the desert
floor by motorized vehicles—all
contribute to exceedance of both PM10
and PM2.5 mass exposure guidelines and
standards.17 Finally, DoD’s report also
stated that PM2.5 levels in the Middle
East are as much as ten times greater
than the levels at both urban and rural
southwestern U.S. air monitoring
sites.18
Dust storms and high windblown dust
concentrations are one of many
environmental hazards experienced
during deployment to locations within
U.S. Central Command. Windblown
dust in these locations is considered an
airborne hazard because it combines
with elemental carbon and metals that
arise from transportation and industrial
activities.19 Although dust in these
locations can be toxic based on
transportation and industrial activities
11 Department of Defense. Open Burn Pit Report
to Congress. 2019. https://www.acq.osd.mil/eie/
Downloads/Congress/Open%20Burn%20Pit%20
Report-2019.pdf.
12 See Defense Letter, supra.
13 Center of Military History, United States Army.
United States Forces, Somalia After Action Report
and Historical Overview: The United States Army
in Somalia, 1992–1994. https://
www.history.army.mil/html/documents/somalia/
index.html.
14 CRS Report R42738, Instances of Use of United
States Armed Forces Abroad, 1798–2022, https://
crsreports.congress.gov/product/pdf/R/R42738/38;
Stimson Center, U.S. Security Assistance to
Somalia, https://www.stimson.org/2023/us-securitycooperation-with-somalia/.
15 Department of Defense. Enhanced Particulate
Matter Surveillance Program Final Report. 2008.
https://apps.dtic.mil/sti/pdfs/ADA605600.pdf
(hereinafter ‘‘EPMSP Report’’).
16 Id.
17 Id.
18 Id.
19 NASEM 2011 Report, supra.
VerDate Sep<11>2014
16:04 Dec 31, 2024
Jkt 265001
alone, open air burn pits increase the
concentration of toxins in PM2.5.
As discussed above, in locations that
rely on open burning of waste, the PM2.5
air pollution in that location will
contain toxic combustion emissions.
Open burning is the ‘‘burning of any
matter in such a manner that products
of combustion resulting from the
burning are emitted directly into the
ambient or surrounding outside air
without passing through an adequate
stack, duct or chimney.’’ 20 The
Environmental Protection Agency (EPA)
defines ‘‘ambient air’’ as ‘‘that portion of
the atmosphere, external to buildings, to
which the general public has access.’’ 40
CFR 50.1(e). Because PM2.5 is a form of
ambient air pollution and open burning
of waste emits toxic combustion
emissions into the ambient air, VA
considers exposure to PM2.5 as
encompassing exposure to burn pit
smoke.
The 38 U.S.C. 1119(c) locations have
a history of annual PM2.5 levels that
exceed military and EPA air quality
standards. Not only do they exceed air
quality standards, average PM2.5
concentrations have been increasing in
North Africa and the Middle East since
1990, while Europe and North America
have experienced decreasing trends in
average PM2.5 concentrations.21 Based
on evidence of burn pit use, PM2.5 levels
that exceed military and EPA air quality
standards, and their arid desert climate
conditions that exacerbate PM2.5 levels,
VA finds there is sufficient evidence to
extend the presumption of exposure to
PM2.5 beyond the locations listed in 38
CFR 3.320 to Egypt, Jordan, Lebanon,
Somalia, and Yemen. Moreover, for
consistency with 38 U.S.C.
1119(c)(1)(B), which presumes toxic
exposure in certain countries (including
Afghanistan, Syria, Djibouti, and
Uzbekistan) back to September 11, 2001,
new 38 CFR 3.320a will have a
presumption of exposure for Veterans
who served in those countries on or
after September 11, 2001.
VA notes that the PACT Act’s
definition of a ‘‘covered Veteran’’ in 38
U.S.C. 1119(c) does not include all areas
historically included in the Southwest
Asia theater of operations, omitting the
neutral zone between Iraq and Saudi
Arabia, the Gulf of Aden, the Gulf of
Oman, the Persian Gulf, the Arabian
Sea, and the Red Sea. However, in this
IFR, VA shall maintain the locations
currently included in the Southwest
20 Estrellan, C.R. and Iino, F. (2010) Toxic
Emissions from Open Burning. Chemosphere, 80,
193–207. https://doi.org/10.1016/
j.chemosphere.2010.03.057.
21 EPMSP Report, supra.
PO 00000
Frm 00025
Fmt 4700
Sfmt 4700
25
Asia theater of operations under 38 CFR
3.317(e)(2) and 3.320(a)(6), as that list
was based on Executive Order 12744 of
January 21, 1991, which designated the
combat zone of the Persian Gulf War.
Doing so allows individuals with
service in those locations to still qualify
as covered veterans under 38 CFR
3.320a. VA will carry over the definition
of ‘‘Southwest Asia Theater of
Operations’’ from 38 CFR 3.317(e)(2)
and 3.320(a)(6) into 38 CFR 3.320a.
b. Urinary Bladder, Ureter, and Related
Cancers
The PACT Act presumption
determination process consists of four
phases. The Ongoing Exploratory
Surveillance Phase includes
collaborating with VA partners, to
include Veterans Service Organizations
and other stakeholders, to identify,
monitor, and investigate potential toxic
exposures and adverse health effects. 38
U.S.C. 1172(a). The Research and
Assessment Phase involves collecting
information, evidence, and data
regarding a particular toxic exposure
and adverse health effect, and
potentially conducting a scientific study
and analysis of the data. 38 U.S.C.
1172(c). Based on the findings, VA’s
Military Environment Exposures SubCouncil (MEESC) may recommend that
the Secretary initiate a formal
evaluation of the issue. 38 U.S.C.
1172(d).
If the Secretary adopts that
recommendation, the Formal Evaluation
Phase begins. 38 U.S.C. 1173. In this
phase, a technical working group is
convened to conduct an evaluation of
the evidence and research collected in
the prior phases, as well as claims data,
to render a conclusion on the strength
of the evidence, and to provide a
recommendation to the Secretary with
respect to a presumption. 38 U.S.C.
1173. If the Secretary decides to accept
the recommendation, the Rulemaking
and Implementation Phase then begins.
38 U.S.C. 1174.
Here, after research and assessment,
and at the MEESC’s recommendation,
on February 26, 2024, the Secretary
initiated a formal evaluation of GU
cancers and their possible association
with exposure to PM2.5 pollution in the
Southwest Asia Theater of Operations.
In April 2024, the formal evaluation
concluded and the recommendation was
to establish a presumption.22 On June
25, 2024, the recommendation was
conveyed to the Secretary. On October
25, 2024, the Secretary accepted the
22 The MEESC report (hereinafter MEESC Report)
is attached to this rulemaking, available at
www.regulations.gov.
E:\FR\FM\02JAR1.SGM
02JAR1
ddrumheller on DSK120RN23PROD with RULES1
26
Federal Register / Vol. 90, No. 1 / Thursday, January 2, 2025 / Rules and Regulations
recommendation, paving the way for
this rulemaking.
Under 38 U.S.C. 1173(b), a formal
evaluation shall be based on the review
of available scientific literature,
including human, toxicological, animal,
and methodological studies, and other
factors, and must consider claims data
including claim rate, grant rate, and
service connection prevalence. It can
also consider the level of disability and
mortality caused by the health effects
related to the case of toxic exposure
being evaluated; the quantity and
quality of the information available and
reviewed; the feasibility of and period
for generating relevant information and
evidence; whether such health effects
are combat or deployment related; the
ubiquity or rarity of the health effects;
and any time frame during which a
health effect must become manifest.
A formal evaluation shall review
scientific evidence in a manner that
conforms to principles of scientific and
data integrity; must be free from
suppression or distortion of scientific or
technological findings, data,
information, conclusions, or technical
results; must evaluate the likelihood
that a positive association exists
between an illness and a toxic exposure
while serving in the active military,
naval, air, or space service; and
determine whether the evidence
supports a finding of a positive
association between the toxic exposure
and the illness. 38 U.S.C. 1173(c).
The Secretary had 160 days from June
25, 2024 (i.e., until December 2, 2024)
to make a decision on the formal
evaluation’s recommendation. 38 U.S.C.
1174(a). The Secretary accepted the
recommendation long before the 160
days, on October 25, 2024, paving the
way for this rulemaking.
Throughout this process, the MEESC
considered whether VA should expand
the PACT Act’s existing organ-specific
presumptions to organ-system
presumptions based on common
embryologic development, proximity to
each other, and use of common
structural pathways. For example,
kidney/renal cancers are covered under
the PACT Act, as are all reproductive
organs. The MEESC considered whether
it made sense from a clinical and/or
scientific standpoint to cover a
significant portion of the GU system
(made up of the urinary and
reproductive systems) but exclude other
organs within this same system.
As further discussed below, the GU
system is composed of kidneys, ureters,
urinary bladder, urethra, reproductive,
and genital organs. The PACT Act
provided a presumption for kidney/
renal cancer and all reproductive organ
VerDate Sep<11>2014
16:04 Dec 31, 2024
Jkt 265001
cancers for certain veterans; however, it
did not include ureteral, urinary
bladder, and several related cancers of
the GU system. VA has determined it is
necessary and clinically appropriate to
consider expanding presumptive status
to cancers of these additional organs for
specific veteran populations. Clinical
and scientific review provides a strong
scientific rationale to add the urinary
bladder, ureters, and associated
structures.
The GU system as a whole
encompasses the reproductive and
urinary system organs. These organs are
usually grouped together because of a
common embryological origin,
proximity to each other, and use of
common structural pathways.23 The GU
system shares common embryologic,
anatomic, structural, and functional
relationships through the intermediate
mesoderm, splanchnopleuric
mesoderm, and the endoderm.24
The urinary system’s function is to
filter blood and create urine as a waste
by-product. The organs of the urinary
system include the kidneys, renal
pelvis, ureters, bladder, and urethra.25
The kidneys and ureters form early in
the embryotic period, after which the
bladder and urethra are formed.26 Week
four of gestation commences with the
development of the urinary tract, which
includes the kidney, ureter, and urinary
bladder. Bladder development is
comprised of the intermediate
mesenchyme (embryonic connective
tissue in the mesoderm) and occurs
when the urogenital septum divides.27
Once the bladder is formed, it connects
to the other organs. As the kidneys
ascend, the ureters elongate and open
into the bladder superiorly, while the
roots of the mesonephric ducts are
carried inferiorly, before fusing to form
the trigone region. Endodermal cells
from the urogenital sinus soon replace
the mesodermal cells epithelium of the
trigone region, thus completing
development.
Between 32–36 weeks gestation, this
development is completed and the
organs become distinct. The urachus, an
embryonic remnant, connects the
23 Genitourinary System, Science Direct. https://
www.sciencedirect.com/topics/medicine-anddentistry/genitourinary-system.
24 Rehman S, Ahmed D, (Aug 8, 2023).
Embryology, Kidney, Bladder, and Ureter.
StatPearls [internet]. https://www.ncbi.nlm.nih.gov/
books/NBK547747/ (hereinafter ‘‘Rehman’’).
25 Anatomy of the Urinary System. https://
www.hopkinsmedicine.org/health/wellness-andprevention/anatomy-of-the-urinary-system.
26 Kucharz, E.J. (1992). Urinary and Reproductive
Systems. In: The Collagens: Biochemistry and
Pathophysiology. Springer, Berlin, Heidelberg.
https://doi.org/10.1007/978-3-642-76197-3_18.
27 Rehman, supra.
PO 00000
Frm 00026
Fmt 4700
Sfmt 4700
bladder to the umbilical cord during
fetal development and is the main fetal
excretory organ. After birth, this tube
closes and becomes a ligament, although
it fails to close some cases.28
The kidney consists of various cell
types originating from the ureteric bud
and the metanephrogenic mesenchyme,
which differentiate into more than 26
different cell types in the kidney. The
ureteric bud contributes to the
development of the ureter and parts of
the kidney, which serves a critical role
in the formation of the renal collecting
system.29 Embryologically, the
urothelium of the urinary bladder and
urethra is derived from the ventral
urogenital sinus, like the epithelium in
the renal pelvis and ureters.30 In utero,
the intermediate mesoderm forms the
kidneys, ureters, and renal vasculature.
The splanchnopleuric mesoderm forms
the smooth muscle and connective
tissue of the bladder. The endoderm
forms the inner bladder and urethra.31
The development of the ureter and
kidney cells are closely linked through
the interaction of the ureteric bud and
metanephric mesenchyme, leading to
the formation of the complex structures
of the urinary system.32 The urethra in
the neck of the bladder develops into
the male urethra prostatic part, and
female urethra.33
The organs of the GU system are
necessarily interrelated. The kidneys
filter waste and fluid, including toxic
exposures that get into the body, to
produce urine. Once the kidneys
produce the urine, it is transported from
28 See MEESC memorandum, ‘‘Additional
Clarification and Details on Genitourinary Cancer
Formal Evaluation in Support of Rulemaking’’
dated November 6, 2024 (hereinafter MEESC
Memorandum), attached to this rulemaking,
available at www.regulations.gov.
29 Qais Al-Awqati; Juan A. Oliver, (February
2002). Stem Cells in the Kidney. Kidney
International, Volume 61, Issue 2. https://
www.sciencedirect.com/science/article/pii/
S0085253815482262?via%3Dihub.
30 Guo-Xia Tong, Woojin M Yu, Nike T Beaubier,
et al., (September 2009) Expression of PAX8 in
Normal and Neoplastic Renal Tissues: An
Immunohistochemical Study. Modern Pathology,
Volume 22, Issue 9, 1218–1227. https://
www.sciencedirect.com/science/article/pii/
S0893395222024747?via%3Dihub.
31 Rehman, supra.
32 Shah MM, Tee JB, Meyer T, Meyer-Schwesinger
C, Choi Y, Sweeney DE, Gallegos TF, Johkura K,
Rosines E, Kouznetsova V, Rose DW, Bush KT,
Sakurai H, Nigam SK. The instructive role of
metanephric mesenchyme in ureteric bud
patterning, sculpting, and maturation and its
potential ability to buffer ureteric bud branching
defects. Am J Physiol Renal Physiol. 2009
Nov;297(5):F1330–41. doi: 10.1152/
ajprenal.00125.2009. Epub 2009 Sep 2. Erratum in:
Am J Physiol Renal Physiol. 2010
May;298(5):F1285. PMID: 19726549; PMCID:
PMC2781331, https://pubmed.ncbi.nlm.nih.gov/
19726549/.
33 Rehman, supra.
E:\FR\FM\02JAR1.SGM
02JAR1
Federal Register / Vol. 90, No. 1 / Thursday, January 2, 2025 / Rules and Regulations
the kidneys to the urinary bladder by
the ureters, which are bilateral tubular
structures that connect the kidneys to
the urinary bladder. The openings of the
ureters into the urinary bladder are
called the ureteric orifices. The urine,
which contains the waste that was
filtered from the body by the kidneys, is
stored in the urinary bladder until it is
time to urinate. When it is time to
urinate, the urethra, a small tube, allows
the urine to pass outside the body.
As discussed, the GU system cancers
share common embryologic, anatomic,
structural, and functional relationships.
Necessarily, each of these organs is
exposed to the waste/toxins, starting in
the kidneys, which is turned into urine.
The urothelium is exposed to toxins in
the urine, so that any carcinogenic effect
would also be expected in the bladder
and ureter. The urine exposes the
remaining GU structures to the toxins
and any resultant carcinogens,
including PM2.5.34 Hence, any
carcinogens in the kidneys or bladder
necessarily pass through the remainder
of the GU system, providing the
exposure to carcinogens to each part of
the GU system.
1. Association Between PM2.5 and
Urinary Bladder Cancer
In support of this rulemaking, as
required by 38 U.S.C. 1173, VA
conducted a formal evaluation of
whether a sufficient association between
PM2.5 and bladder cancer existed. The
results of the studies reviewed by VA’s
experts showed an association between
PM2.5 and bladder cancer and that 6–
19% of bladder cancers are attributable
to occupational exposures. Studies from
2003 to 2022 supported the association
between PM2.5 and bladder cancer.
A 2003 study estimated occupational
exposure caused death due to bladder
cancer for 534 to 1,451 men and 116 to
740 women annually.35 Nine years later,
the International Association for
Research on Cancer (IARC) also found
evidence that air pollution was
associated with developing bladder
cancer.36 In 2017, another study
positively correlated the concentration
of ambient PM2.5 with development of,
34 MEESC
Report, supra.
K, Burnett C, Lalich, et al., (May,
2003). Dying for work: The magnitude of US
mortality from selected causes of death associated
with occupation. Am J Ind Med. 43(5):461–82.
https://pubmed.ncbi.nlm.nih.gov/12704620/.
36 IARC (International Association for Research
on Cancer). Air Pollution and Cancer, IARC
Scientific Publication No. 161, 2013. https://
publications.iarc.fr/Book-And-Report-Series/IarcScientific-Publications/Air-Pollution-And-Cancer2013.
ddrumheller on DSK120RN23PROD with RULES1
35 Steenland
VerDate Sep<11>2014
16:04 Dec 31, 2024
Jkt 265001
and death from, bladder cancer.37 That
same year a study also found airborne
pollution and particulate matter posed
an elevated risk for bladder cancer.38
Two 2020 studies similarly found an
elevated hazard ratio between exposure
to air pollution and PM and the
development of bladder cancer,
concluding such exposures may be a
risk factor for bladder cancer.39
According to a 2020 scientific review of
bladder and kidney cancer, studies
suggested positive, even though mostly
non-significant, associations between air
pollution exposure, including PM2.5,
and bladder cancer mortality and
kidney cancer incidence. Bladder cancer
showed a positive association: bladder
cancer mortality had an adjusted oddsratio of an average of 13% percent with
a slight increase of PM2.5. r.40
The EPA also concluded that longterm exposure to PM2.5, in the form of
diesel exhaust emissions, has a likely
causal relationship to the development
of bladder cancer.41 This is supported
by a 2022 EPA study.42 Supporting the
previous studies, a 2022 large pooled
study found evidence of an association
between long-term PM2.5 mass exposure
and bladder cancer. A 2024 study
performed a meta-analysis which
combined the results of from 18 cohort
studies, 10 case-control studies, and
nine ecological studies, studies
published through early 2024. The
authors stated that a 5 microgram
increase per cubic meter in the
atmosphere in PM2.5 was significantly
37 Yeh, H.L., Hsu, S.W., Chang, Y.C., Chan, T.C.,
Tsou, H.C., Chang, Y.C., & Chiang, P.H. (2017).
Spatial Analysis of Ambient PM2.5 Exposure and
Bladder Cancer Mortality in Taiwan. International
journal of environmental research and public
health, 14(5), 508; https://pmc.ncbi.nlm.nih.gov/
articles/PMC5451959.
38 Turner MC, Krewski D, Diver WR, Pope CA
3rd, Burnett RT, Jerrett M, Marshall JD, Gapstur SM.
Ambient Air Pollution and Cancer Mortality in the
Cancer Prevention Study II. Environ Health
Perspect. 2017 Aug 21;125(8):087013; https://
ehp.niehs.nih.gov/doi/10.1289/EHP1249.
39 Coleman NC, Burnett RT, Higbee JD, Lefler JS,
Merrill RM, Ezzati M, Marshall JD, Kim SY, Bechle
M, Robinson AL, Pope CA 3rd. Cancer mortality
risk, fine particulate air pollution, and smoking in
a large, representative cohort of US adults. Cancer
Causes Control. 2020 Aug;31(8):767–776. (hereafter
Cancer mortality risk); https://
pubmed.ncbi.nlm.nih.gov/32462559.
40 Zare Sakhvidi MJ, Lequy E, Goldberg M,
Jacquemin B. Air pollution exposure and bladder,
kidney and urinary tract cancer risk: A systematic
review. Environ Pollut. 2020 Dec;267:115328;
https://www.sciencedirect.com/science/article/abs/
pii/S0269749120360164?via%3Dihub.
41 EPA Supplement to the 2019 Integrated
Science Assessment for Particulate Matter (Final
Report, 2022) https://www.epa.gov/isa/integratedscience-assessment-isa-particulate-matter (hereafter
‘‘EPA supplement’’).
42 Id.
PO 00000
Frm 00027
Fmt 4700
Sfmt 4700
27
associated with an increased relative
risk for bladder cancer of 7%.43
PM2.5 exposure is of concern for those
deployed to the Southwest Asia Theater
of operations and other known BPOT
locations. VA has already examined
studies by NASEM on the contribution
of air pollution to adverse health effects
among U.S. Service members serving in
the Middle East.44 86 FR at 42725–
42726. Thus, VA has determined that it
will consider bladder cancers for this
population to be associated with
exposure to PM2.5. Accordingly, VA
concludes it is appropriate to add
bladder cancer to 38 CFR 3.320a.
2. Association Between PM2.5 and
Cancers of the Ureter, Ureteric Orifice,
Urachus, Over-Lapping and Sites of the
Bladder
Ureter cancer is a rare type of cancer;
however, between 5% and 10% of all
urothelial cancers start in the ureter.45
As discussed above, all parts of the GU
system share the same embryonic origin.
The development of ureter and kidney
cells is closely linked through the
interaction of the ureteric bud and
metanephric mesenchyme, leading to
the formation of the complex structures
of the urinary system.
The PACT Act has associated kidney
cancer with PM2.5 for certain Veterans.
The kidneys transport waste into the
ureters.46 From the ureters, the ureteric
orifices empty the urine into the urinary
bladder. Each of these organs is exposed
to waste and toxins produced by the
kidneys, thus exposing them to any
carcinogens.47 Accordingly, the same
PM2.5 that affected the kidneys
necessarily affects the entire GU tract.
Because individuals with renal pelvis or
ureter cancer can develop cancer in the
kidneys and/or bladder over time,48
there are common risk factors for cancer
development throughout the
uroepithelium. As such, VA concludes
43 Li J, Deng Z, Soerensen SJC, Kachuri L,
Cardenas A, Graff RE, Leppert JT, Langston ME,
Chung BI. Ambient air pollution and urological
cancer risk: A systematic review and meta-analysis
of epidemiological evidence. Nat Commun. 2024
Jun 15;15(1):5116, https://pmc.ncbi.nlm.nih.gov/
articles/PMC11180144/.
44 NASEM, Gulf War and Health Series: Volume
3: Fuels and Products of Combustion (2005),
https://doi.org/10.17226/11180 and Volume 11:
Generational Health Effects of Serving in the Gulf
War (2018), https://doi.org/10.17226/25162.
NASEM, Respiratory Health Effects of Airborne
Hazards Exposures in the Southwest Asia Theater
of Military Operations (2020), https://doi.org/
10.17226/25837.
45 Saint John’s Cancer Institute. Ureteral Cancer
and Ureteral Urothelial Carcinoma (UTUC).https://
www.saintjohnscancer.org/urology/conditions/
ureteral-cancer/.
46 MEESC Memorandum, supra.
47 Id.
48 MEESC Report, supra.
E:\FR\FM\02JAR1.SGM
02JAR1
28
Federal Register / Vol. 90, No. 1 / Thursday, January 2, 2025 / Rules and Regulations
that bladder, ureter, and kidney cancers
should all be treated the same for
purposes of the presumption.49
ddrumheller on DSK120RN23PROD with RULES1
III. Addition of Urinary Bladder,
Ureter, and Related Cancers to 38 CFR
3.320a
Since August 5, 2021, VA has
presumed for certain Veterans that
asthma, rhinitis, or sinusitis are
associated with PM2.5. 38 CFR
3.320(a)(2); 86 FR at 42732–42733. VA
added nine rare cancers to the list of
disabilities presumptively associated
with PM2.5 on April 26, 2022. 38 CFR
3.320(a)(3); 87 FR 24421, 24429 (2022).
VA instituted these presumptions based
on scientific and medical studies, which
focused on the respiratory effects of
PM2.5 for veterans who served in the
Southwest Asia theater of operations,
Afghanistan, Syria, Djibouti, and
Uzbekistan during the Gulf War. 86 FR
at 42729; 87 FR at 24424–24525.
As discussed above, in the PACT Act,
Congress enacted a presumption
associating kidney cancer and
reproductive cancers (which includes
male urethra and prostate cancer) with
toxic exposures in covered locations. 38
U.S.C. 1120(b)(2)(E), (G). Although the
PACT Act covers almost 73% of existing
cancers, it did not include all
genitourinary tract cancers.50 Yet
Congress authorized VA to enact
additional presumptions based on a
positive association with a substance,
chemical, or airborne hazard. 38 U.S.C.
1120(b)(15). Because urinary bladder
cancer is related to PM2.5 inhalation and
BPOT exposure, and cancers of the
ureter and related cancers receive toxins
in the same manner as the bladder, VA
concludes they should be extended a
presumption in new 38 CFR 3.320a.
As discussed above, VA is enacting
this presumption pursuant to the 38
U.S.C. 1171 et seq. process. But VA also
notes the alternative authority to add
these presumptions under 38 U.S.C.
501(a)(1), which permits VA to issue
necessary or appropriate regulations
with respect to the nature and extent of
proof and evidence in order to establish
rights to benefits, such as presumptions
of service connection.
IV. New 38 CFR 3.320a
VA will use the heading of
‘‘[p]resumptive service connection for
bladder, ureter, and related
genitourinary cancers’’ for 38 CFR
3.320a. VA will describe the
presumption of exposure in paragraph
(a), describe the presumptions of service
connection in paragraph (b), provide the
49 Id.
50 MEESC
Report, supra.
VerDate Sep<11>2014
16:04 Dec 31, 2024
Jkt 265001
definition of covered veteran in
paragraph (c), and provide the standard
exceptions for presumptions in
paragraph (d).
Although this rulemaking is based on
current medical and scientific evidence
related to the respiratory health effects
of PM2.5 on veterans who served during
the Gulf War and are otherwise covered
by the PACT Act, VA will continue to
review new scientific evidence as it
develops regarding all health effects
resulting from exposure to BPOT,
including PM2.5. This rulemaking does
not limit the future establishment of
additional presumptions of service
connection.
V. Severability
The purpose of this section is to
clarify the agency’s intent with respect
to the severability of provisions of this
rule. Each provision of this rule is
capable of operating independently. If
any provision of this rule is determined
by judicial review or operation of law to
be invalid, that partial invalidation will
not render the remainder of this
rulemaking invalid. Likewise, if the
application of any portion of this rule to
a particular circumstance is determined
to be invalid, the agency intends that
the rule remain applicable to all other
circumstances.
Administrative Procedure Act
Pursuant to 5 U.S.C. 553(b)(B) and
(d)(3), VA has concluded that there is
good cause to publish the IFR without
prior opportunity for comment and to
publish the rule with an immediate
effective date. There is good cause to
immediately address the needs of
Service members and veterans who have
been exposed to airborne hazards, i.e.,
PM2.5, due to their service in the
Southwest Asia theater of operations,
Afghanistan, Syria, Djibouti,
Uzbekistan, Somalia, Egypt, Jordan,
Lebanon, and Yemen.
VA concludes that the ordinary
notice-and-comment procedures here
would be impracticable, in that they
would cause Veterans serious harm by
further delaying and in some cases
outright preventing Veterans from
receiving the benefits of these
presumptions given the nature of the
diseases at issue. In particular, bladder
and ureter cancers are diseases of
significant morbidity and mortality.
Bladder cancer alone is fairly common
and causes morbidity and mortality.
According to the latest national
statistics available from the Centers for
Disease Control and Prevention (CDC)
which were from 2021, bladder cancer
is the seventh most common cancer in
the U.S. with a rate of 18.1 cases per
PO 00000
Frm 00028
Fmt 4700
Sfmt 4700
100.000 persons.51 In 2021, 75,450 new
cases of urinary bladder cancer were
reported in the U.S.52 In 2022, which is
the latest year for which CDC has
available mortality data, 17,334 people
died of urinary bladder cancer in the
U.S. Most of the deaths were in men,
according to the CDC.53 In 2022, the
latest year for which mortality data are
available, in the United States, 12,460
men died of urinary cancer.54 For ureter
cancer, the five-year survival rate is 5%
or less.55
Overall, delaying this rulemaking for
notice and comment runs the real risk
of harming the very population this
rulemaking intends to help. Moreover,
the 38 U.S.C. 1119(c) locations are
dictated by Congress; they cannot be
removed by either VA or public
comment.
The new presumptions are entirely
pro-claimant in nature. They do not
adversely affect any person. And
because VA has a sufficient scientific
basis to support the new presumptions,
withholding the presumptions during
the notice and comment process could
unnecessarily deprive veterans and
beneficiaries of benefits to which they
would otherwise be entitled and
prolong their inability to timely receive
benefits. Additionally, this could create
risks to beneficiaries’ welfare and health
that would be exacerbated by any
additional delay in implementation.
Due to the complexity and the historical
scientific uncertainty surrounding these
issues of airborne hazard exposures and
disease, many veterans who will be
affected by this rule have long borne the
burden and expense of their disabilities
while awaiting the results of research
and investigation. Under these
circumstances, there is good cause to
avoid further delay on their receipt of
benefits, potentially at the risk of their
welfare and health.
Overall, the Secretary’s decision to
extend new presumptions to veterans
who have been exposed to PM2.5 due to
their service in the Southwest Asia
theater of operations, and Somalia,
Afghanistan, Djibouti, Egypt, Jordan,
Lebanon, Syria, Yemen, and Uzbekistan
requires immediate effect to help them
access these benefits without undue
delay. For veterans that are not
otherwise eligible for health care, these
presumptions could result in needed
51 United States Cancer Statistics: Data
Visualizations, https://gis.cdc.gov/Cancer/USCS/#/
AtAGlance/.
52 Id.
53 Id.
54 Id.
55 Social Security Administration, Program
Operations Manual System, https://secure.ssa.gov/
poms.nsf/lnx/0423022345.
E:\FR\FM\02JAR1.SGM
02JAR1
Federal Register / Vol. 90, No. 1 / Thursday, January 2, 2025 / Rules and Regulations
ddrumheller on DSK120RN23PROD with RULES1
health care eligibility based on service
connection.
Section 553(d) of 5 U.S.C. also
requires a 30-day delayed effective date
following publication of a rule, except
for ‘‘(1) a substantive rule which grants
or recognizes an exemption or relieves
a restriction, (2) interpretative rules and
statements of policy, or (3) as otherwise
provided by the agency for good cause
found and published with the rule.’’
Pursuant to section 553(d)(3), the
Secretary finds that there is good cause
to make the rule effective upon
publication, for the reasons discussed
above.
For the foregoing reasons, and as
explained in further detail in the IFR,
the Secretary of Veterans Affairs is
issuing this rule as an IFR with an
immediate effective date. However, VA
will consider and address comments
that are received within 60 days of the
date this IFR is published in the Federal
Register.
Executive Orders 12866, 13563, and
14094
Executive Order 12866 (Regulatory
Planning and Review) directs agencies
to assess the costs and benefits of
available regulatory alternatives and,
when regulation is necessary, to select
regulatory approaches that maximize
net benefits (including potential
economic, environmental, public health
and safety effects, and other advantages;
distributive impacts; and equity).
Executive Order 13563 (Improving
Regulation and Regulatory Review)
emphasizes the importance of
quantifying both costs and benefits,
reducing costs, harmonizing rules, and
promoting flexibility. Executive Order
14094 (Executive Order on Modernizing
Regulatory Review) supplements and
reaffirms the principles, structures, and
definitions governing contemporary
regulatory review established in
Executive Order 12866 of September 30,
1993 (Regulatory Planning and Review),
and Executive Order 13563 of January
18, 2011 (Improving Regulation and
Regulatory Review). The Office of
Information and Regulatory Affairs has
determined that this rulemaking is a
significant regulatory action under
Executive Order 12866, Section 3(f)(1),
as amended by Executive Order 14094.
The Regulatory Impact Analysis
associated with this rulemaking can be
found as a supporting document at
www.regulations.gov.
Unfunded Mandates
The Unfunded Mandates Reform Act
of 1995 requires, at 2 U.S.C. 1532, that
agencies prepare an assessment of
anticipated costs and benefits before
VerDate Sep<11>2014
16:04 Dec 31, 2024
Jkt 265001
issuing any rule that may result in the
expenditure by state, local, and tribal
governments, in the aggregate, or by the
private sector, of $100 million or more
(adjusted annually for inflation) in any
one year. This IFR will have no such
effect on state, local, and tribal
governments, or on the private sector.
Paperwork Reduction Act
Although this interim final rule
contains provisions constituting
collection of information under the
provisions of the Paperwork Reduction
Act of 1995 (44 U.S.C. 3501–3521), there
are no provisions associated with this
rulemaking constituting any new
collection of information or any
revisions to the existing collection of
information. The collection of
information for 38 CFR 3.320a is
currently approved by the Office of
Management and Budget (OMB) and has
been assigned OMB control numbers
2900–0747, 2900–0886, 2900–0004, and
2900–0002.
Congressional Review Act
Under the Congressional Review Act,
this regulatory action may result in an
annual effect on the economy of $100
million or more, 5 U.S.C. 804(2), and so
is subject to the 60-day delay in
effective date under 5 U.S.C. 801(a)(3).
In accordance with 5 U.S.C. 801(a)(1),
VA will submit to the Comptroller
General and to Congress a copy of this
Regulation and the Regulatory Impact
Analysis (RIA) associated with the
Regulation.
List of Subjects in 38 CFR Part 3
Administrative practice and
procedure, Claims, Disability benefits,
Health care, Pensions, Veterans.
Signing Authority
Denis McDonough, Secretary of
Veterans Affairs, signed and approved
this document on December 20, 2024,
and authorized the undersigned to sign
and submit the document to the Office
of the Federal Register for publication
electronically as an official document of
the Department of Veterans Affairs.
Michael P. Shores,
Director, Office of Regulation Policy &
Management, Office of General Counsel,
Department of Veterans Affairs.
For the reasons stated in the
preamble, the Department of Veterans
Affairs amends 38 CFR part 3 as set
forth below:
PO 00000
Frm 00029
Fmt 4700
Sfmt 4700
29
PART 3—ADJUDICATION
Subpart A—Pension, Compensation,
and Dependency and Indemnity
Compensation
1. The authority citation for part 3
continues to read as follows:
■
Authority: 38 U.S.C. 501(a), unless
otherwise noted.
■
2. Add § 3.320a to read as follows:
§ 3.320a Presumptive service connection
for bladder, ureter, and related
genitourinary cancers.
(a) Presumption of exposure. A
covered veteran as defined in paragraph
(c) of this section shall be presumed to
have been exposed to certain toxic
substances, chemicals, and airborne
hazards, including fine particulate
matter, during such service, unless there
is affirmative evidence to establish that
the veteran was not exposed to any such
toxic substances, chemicals, and
airborne hazards during that service.
(b) Presumption of service connection.
Except as provided in paragraph (d) of
this section, the following diseases
becoming manifest in a covered veteran,
as defined in paragraph (c) of this
section, shall be considered to have
been incurred in or aggravated during
active military, naval, air, or space
service, notwithstanding that there is no
record of evidence of such disease
during the period of such service:
(1) Urinary bladder cancer, including
over-lapping sites of the bladder.
(2) Ureter cancer, including the
ureteric orifice, and urachus.
(c) Covered Veteran. For purposes of
this section, the term covered veteran
means any veteran who:
(1) On or after August 2, 1990,
performed active military, naval, air, or
space service while assigned to a duty
station in, including airspace above
(i) The Southwest Asia theater of
operations as defined in § 3.317(e)(2); or
(ii) Somalia; or
(2) On or after September 11, 2001,
performed active military, naval, air, or
space service while assigned to a duty
station in, including airspace above:
(i) Afghanistan;
(ii) Djibouti;
(iii) Egypt;
(iv) Jordan;
(v) Lebanon;
(vi) Syria;
(vii) Yemen; or
(viii) Uzbekistan.
(d) Exceptions. A disease listed in
paragraph (b) of this section shall not be
presumed service connected if there is
affirmative evidence that:
(1) The disease was not incurred or
aggravated during active military, naval,
air, or space service; or
E:\FR\FM\02JAR1.SGM
02JAR1
30
Federal Register / Vol. 90, No. 1 / Thursday, January 2, 2025 / Rules and Regulations
(2) The disease was caused by a
supervening condition or event that
occurred between the Veteran’s most
recent departure from active military,
naval, air, or space service and the onset
of the disease; or
(3) The disease is the result of the
Veteran’s own willful misconduct.
(Authority: 38 U.S.C. 501, 1119, 1120, 1174)
[FR Doc. 2024–31220 Filed 12–31–24; 8:45 am]
FEDERAL MARITIME COMMISSION
46 CFR Part 542
[Docket No. FMC–2023–0010]
RIN 3072–AC92
Definition of Unreasonable Refusal To
Deal or Negotiate With Respect to
Vessel Space Accommodations
Provided by an Ocean Common Carrier
Federal Maritime Commission.
ACTION: Final rule; announcement of
effective date; correction.
AGENCY:
The Federal Maritime
Commission (FMC or Commission)
received approval from the Office of
Management and Budget (OMB) for an
information collection request
associated with the final rule,
‘‘Definition of Unreasonable Refusal to
Deal or Negotiate with Respect to Vessel
Space Accommodations Provided by an
Ocean Common Carrier.’’ This rule
announces the effective date for the
requirements for ocean common carriers
to annually file a documented export
policy with the Commission and
provides implementing instructions. In
the final rule published July 23, 2024,
the Commission stated it would publish
a document in the Federal Register (FR)
announcing the effective date of the
collection-of-information-related
sections upon OMB approval. This rule
establishes the effective date of the
relevant provisions. It also corrects an
error in the regulatory text.
DATES: The amendments adding 46 CFR
542.1(j) (instruction 2) and 46 CFR
542.99 (instruction 3), published on July
23, 2024 (89 FR 59648), are effective on
February 3, 2025. The correction to 46
ddrumheller on DSK120RN23PROD with RULES1
SUMMARY:
16:04 Dec 31, 2024
Background documents
associated with this collection are
available on www.reginfo.gov (search
OMB Control No. 3072–0076) and
www.regulations.gov (search Docket No.
FMC–2023–0010).
FOR FURTHER INFORMATION CONTACT:
David Eng, Secretary; Phone: (202) 523–
5725; Email: secretary@fmc.gov.
SUPPLEMENTARY INFORMATION: On July
23, 2024, in accordance with the Ocean
Shipping Reform Act of 2022, the
Federal Maritime Commission
published the final rule, ‘‘Definition of
Unreasonable Refusal to Deal or
Negotiate with Respect to Vessel Space
Accommodations Provided by an Ocean
Common Carrier.’’ The final rule
contained two provisions, 46 CFR
542.1(j), and 46 CFR 542.99, that were
delayed indefinitely, pending
information collection approval from
OMB under the Paperwork Reduction
Act of 1995, 44 U.S.C. 3501–3520. On
September 27, 2024, OMB, Office of
Information and Regulatory Affairs,
approved the information collection
requirements (https://www.reginfo.gov/
public/do/PRAViewICR?ref_
nbr=202407-3072-001). The assigned
OMB Control Number is 3072–0076.
Accordingly, FMC announces that 46
CFR 542.1(j) and 46 CFR 542.99 are
effective February 3, 2025. FMC is also
making a minor correction to 46 CFR
542.99.
ADDRESSES:
BILLING CODE 8320–01–P
VerDate Sep<11>2014
CFR 542.99 is effective February 3,
2025.
Parties required to file a documented
export policy must file their initial
documented export policy with the
Commission on or before March 1, 2025.
Subsequent annual documented export
policies must subsequently be filed on
or before March 1 for each calendar
year.
Jkt 265001
Filing Instructions
Unless superseded by subsequent
Commission order or filing instructions
issued by the Commission:
1. Parties required under 46 CFR
542.4(j) to file a documented export
policy must file their initial
documented export policy with the
Commission on or before March 1, 2025.
Subsequent annual documented export
PO 00000
Frm 00030
Fmt 4700
Sfmt 9990
policies must be filed with the
Commission on or before March 1 of
each calendar year. A documented
export policy should cover the time
period until the next policy is due for
submission; carriers may file updated
versions more frequently as needed.
2. Documents must be submitted in
English, and any monetary terms shall
be expressed in terms of U.S. currency.
3. If any topics listed under
541.2(j)(1)(i), 541.2(j)(1)(ii), and/or
541.2(j)(1)(iii) are not addressed in a
documented export policy because they
are not applicable, the documented
export policy should attest to this
inapplicability clearly and
unambiguously and provide an
explanation for non-applicability.
4. Submissions shall be signed by a
duly authorized officer of the regulated
party with a copy of evidence of the
officer’s authority.
List of Subjects in 46 CFR Part 542
Administrative practice and
procedure, Non-vessel-operating
common carriers, Ocean common
carrier, Refusal to deal or negotiate,
Vessel-operating common carriers,
Vessel space accommodations.
For the reasons set forth in the
preamble, FMC corrects 46 CFR part 542
by making the following correcting
amendment:
■ 1. The authority citation for part 542
continues to read as follows:
Authority: 5 U.S.C. 553; and 46 U.S.C.
40104, 46105, 40307, 40501–40503, 40901–
40904, 41101–41106.
■
2. Revise § 542.99 to read as follows:
§ 542.99 OMB control number assigned
pursuant to the Paperwork Reduction Act.
The Commission has received Office
of Management and Budget approval for
the collection of information in
§ 542.1(j) of this part pursuant to the
Paperwork Reduction Act of 1995, as
amended. The valid control number for
this collection is 3072–0076.
By the Commission.
David Eng,
Secretary.
[FR Doc. 2024–31017 Filed 12–31–24; 8:45 am]
BILLING CODE 6730–02–P
E:\FR\FM\02JAR1.SGM
02JAR1
Agencies
[Federal Register Volume 90, Number 1 (Thursday, January 2, 2025)]
[Rules and Regulations]
[Pages 23-30]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-31220]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF VETERANS AFFAIRS
38 CFR Part 3
2900-AS21
Presumptive Service Connection for Bladder, Ureter, and Related
Genitourinary Cancers Due to Exposure to Fine Particulate Matter
AGENCY: Department of Veterans Affairs.
ACTION: Interim final rule.
-----------------------------------------------------------------------
SUMMARY: The Department of Veterans Affairs (VA) is issuing this
interim final rule (IFR) to amend its adjudication regulations to
establish presumptive service connection for urinary bladder, ureter,
and related genitourinary (GU) cancers due to exposure to Particulate
Matter 2.5 (PM2.5) and to implement certain provisions of
the Sergeant First Class Heath Robinson Honoring our Promise to Address
Comprehensive Toxics Act of 2022 (PACT Act). The new presumptions would
apply to Veterans who served on active military, naval, air, or space
service in Southwest Asia theater of operations or Somalia during the
Persian Gulf War (hereafter Gulf War) on or after August 2, 1990, and
in Afghanistan, Syria, Djibouti, Uzbekistan, Egypt, Jordan, Lebanon,
and Yemen during the Gulf War on or after September 11, 2001. This
amendment is necessary to provide expeditious health care, services,
and benefits to these veterans. This IFR addresses the needs and
concerns of Gulf War veterans and Service members who have served and
continue to serve in these locations and have been diagnosed with
bladder, ureter, and related GU cancers. Neither Congress nor the
President has established an end date for the Gulf War. Therefore, to
expedite the provision of health care, services, and benefits to
current and future Gulf War veterans who may be affected by
PM2.5 due to their military service, VA is establishing
presumptive service connection for urinary bladder, ureter, and related
GU cancers. This IFR will ease the evidentiary burden of Gulf War
Veterans who file claims with VA for these conditions.
DATES:
Effective date: This interim final rule is effective January 2,
2025.
Comment date: Comments must be received on or before March 3, 2025.
ADDRESSES: Comments must be submitted through www.regulations.gov.
Except as provided below, comments received before the close of the
comment period will be available at www.regulations.gov for public
viewing, inspection, or copying, including any personally identifiable
or confidential business information that is included in a comment. We
post the comments received before the close of the comment period on
www.regulations.gov as soon as possible after they have been received.
VA will not post on Regulations.gov public comments that make threats
to individuals or institutions or suggest that the commenter will take
actions to harm an individual. VA encourages individuals not to submit
duplicative comments; however, we will post comments from multiple
unique commenters even if the content is identical or nearly identical
to other comments. Any public comment received after the comment
period's closing date is considered late and will not be considered in
the final rulemaking. In accordance with the Providing Accountability
Through Transparency Act of 2023, a plain language summary (not more
than 100 words in length) of this interim final rule is available at
www.regulations.gov, under RIN 2900-AS21.
FOR FURTHER INFORMATION CONTACT: Sara Cohen, Lead, Part 3 Regulations
Staff, Robert Parks, Chief, Part 3 Regulations Staff (211C),
Compensation Service (21C), Veterans Benefits Administration,
Department of Veterans Affairs, 810 Vermont Avenue NW, Washington, DC
20420, (202) 461-9700. (This is not a toll-free telephone number.)
SUPPLEMENTARY INFORMATION:
[[Page 24]]
I. Background
On August 10, 2022, Congress enacted Public Law 117-168, the PACT
Act. The PACT Act provided a process for VA to establish presumptive
service connection based on toxic exposures. 38 U.S.C. 1171 et seq. The
PACT Act also added a presumption of service connection for certain
diseases associated with exposure to burn pits and other toxins (BPOT)
in 38 U.S.C. 1120. This presumption applies to veterans who served in
locations listed in 38 U.S.C. 1119(c)(1). The diseases subject to the
presumption include kidney cancers and ``[r]eproductive cancer of any
type.'' 38 U.S.C. 1120(b)(2)(E), (G). Kidney and reproductive cancers
are part of genitourinary (GU) tract. Although the GU system is
composed of kidneys, ureters, urinary bladder, urethra,\1\ reproductive
and genital organs, including the ureteric orifice, urachus, and over-
lapping sites of the bladder (the urinary organs), the PACT Act did not
address all these organs.
---------------------------------------------------------------------------
\1\ VA does not address urethral cancer in this rulemaking,
because such cancer is a reproductive cancer, and therefore already
subject to presumptive service connection under 38 U.S.C.
1120(b)(2)(E). See 89 FR 79815, 79824 (2024) (proposed rule).
---------------------------------------------------------------------------
Following the 38 U.S.C. 1171 et seq. process, VA determined it was
necessary and clinically appropriate to consider expanding presumptive
status consideration to cancers of these additional organs. One of VA's
priorities is to address the long overdue needs of the Gulf War cohort
and to address the imminent need for these veterans to receive care,
services, and benefits. VA has reviewed both medical and scientific
literature, and concludes that (1) urinary bladder cancer is
sufficiently linked to PM2.5 and that (2) cancers of the
ureter, ureteric orifice, urachus, and over-lapping sites of the
bladder are closely related to urinary bladder cancer with a common
embryologic, anatomical, structural, and functional relationship.
Moreover, the cancers of the ureter, ureteric orifice, urachus, and
over-lapping sites of the bladder are exposed to toxic waste from the
kidneys and the bladder as part of the GU system's function. Because,
as discussed below, there is a medical nexus between the composition
and duration of PM2.5 and airborne hazard exposures to the
development of GU cancers, VA has determined that presumptions of
service connection for these cancers are warranted. See 38 U.S.C.
1174(a)(1).
In this IFR, VA adds 38 CFR 3.320a to its adjudicatory regulations
to presume service connection for these cancers for certain Gulf War
Veterans. VA adds these cancers as presumptive in 38 CFR 3.320a by IFR
so that any Veteran with these cancers and who served in a prescribed
location need not wait for benefits.
II. Scientific Background
a. Exposure to Fine Particulate Matter
On August 5, 2021, VA promulgated 38 CFR 3.320 to establish
presumptions of service connection for certain chronic diseases based
on exposure to PM2.5 during service in the Southwest Asia
theater of operations during the Persian Gulf War, or service in
Afghanistan, Syria, Djibouti, or Uzbekistan, on or after September 19,
2001, during the Persian Gulf War. 86 FR 42724, 42733 (2021) (interim
final rule); see 88 FR 60341 (2023) (adopting the interim final rule
with changes). VA based these presumptions on review and analysis of
airborne hazards in the Southwest Asia theater of operations during the
Persian Gulf War, by examining the National Academies of Science,
Engineering, and Medicine's (NASEM) 2020 report, Respiratory Health
Effects of Airborne Hazards Exposures in the Southwest Asia Theater of
Military Operations; \2\ NASEM's 2011 report, Long-Term Health
Consequences of Exposure to Burn Pits in Iraq and Afghanistan; \3\ and
NASEM's 2010 report, Review of the Department of Defense (DoD) Enhanced
Particulate Matter Surveillance Program.\4\ See 86 FR at 42725-42726.
The 2010 report concluded that Service members deployed to the Middle
East ``are exposed to high concentrations of PM[2.5].'' \5\
See 86 FR at 42725. Toxic compounds present in burn pit fumes include
PM2.5.\6\ This airborne pollution includes smoke from oil
well fires, sand, dust, mechanical fumes from aircraft, vehicle, and
ship engines, wood, plastic, rubber, metals, munitions, chemicals, and
food and human waste.\7\ Incomplete combustion of organic and inorganic
material in burn pits results in high volumes of toxic PM in the air
that includes metals, benzene, and other toxic compounds.\8\
---------------------------------------------------------------------------
\2\ National Academies of Sciences, Engineering, and Medicine
2020. Respiratory Health Effects of Airborne Hazards Exposures in
the Southwest Asia Theater of Military Operations. Washington, DC:
The National Academies Press. https://doi.org/10.17226/25837.
\3\ Institute of Medicine 2011. Long-Term Health Consequences of
Exposure to Burn Pits in Iraq and Afghanistan. Washington, DC: The
National Academies Press. https://doi.org/10.17226/13209
(hereinafter ``NASEM 2011 Report'').
\4\ National Research Council 2010. Review of the Department of
Defense Enhanced Particulate Matter Surveillance Program Report.
Washington, DC: The National Academies Press. https://doi.org/10.17226/12911 (hereinafter ``NRC'').
\5\ NRC, supra.
\6\ Wang X, Doherty TA, James C. Military burn pit exposure and
airway disease: Implications for our Veteran population. Ann Allergy
Asthma Immunol. 2023 Dec;131(6):720-725. doi: 10.1016/
j.anai.2023.06.012. https://pmc.ncbi.nlm.nih.gov/articles/PMC10728339/.
\7\ Id.
\8\ American Cancer Society. Military Burn Pits and Cancer Risk.
2022. https://www.cancer.org/healthy/cancer-causes/chemicals/burn-pits.html.
---------------------------------------------------------------------------
When promulgating 38 CFR 3.320 in August 2021, to determine the
qualifying periods of service, VA primarily considered (1) whether burn
pits were used in the location, (2) the PM2.5 levels, and
(3) desert climates according to 86 FR at 42725-42729. However, in
August 2022, the PACT Act created new 38 U.S.C. 1119, ``Presumptions of
toxic exposure,'' with a different list of qualifying periods of
service. Section 1119(c) defines a ``covered veteran'' as a veteran who
served in the following eligible locations: Bahrain, Iraq, Kuwait,
Oman, Qatar, Saudi Arabia, Somalia, and the United Arab Emirates, on or
after August 2, 1990, and Afghanistan, Djibouti, Egypt, Jordan,
Lebanon, Syria, Yemen, and Uzbekistan on or after September 11, 2001.
In the present rulemaking, after reviewing the three considerations
of burn pit use, PM2.5 levels, and desert climates, VA has
determined that the qualifying periods of service should include both
those listed in 38 CFR 3.320(a)(5) and those listed in 38 U.S.C.
1119(c) to ensure that (1) veterans currently eligible for the
presumption of exposure to PM2.5 in 38 CFR 3.320 and (2)
veterans eligible for the presumption of exposure to BPOT in 38 U.S.C.
1119 are both covered in this rulemaking. Thus, VA's new presumptions
in 38 CFR 3.320a will not simply cover the locations in current 38 CFR
3.320(a)(5), but also the locations listed in 38 U.S.C. 1119(c)
(including Egypt, Jordan, Lebanon, Somalia, and Yemen).
This approach conforms with the information available regarding
documented burn pit use. In 2021, DoD provided Congress with a list of
locations within U.S. Central Command where open burn pits have been
used since 2001.\9\ The U.S. Central Command's Area of Responsibility
consists of 21 nations that stretch from Northeast Africa across the
Middle East to Central and South Asia \10\ and is the only combatant
command that conducts
[[Page 25]]
open burn pit operations.\11\ Egypt, Jordan, Lebanon, and Yemen were
included as locations with open, active burn pits.\12\ Somalia was not
included on the list. However, there is evidence of burn pit use in
Somalia when service members were deployed in support of Operation Show
Care in 1993.\13\ Additional deployments occurred in 1992, 1995, 2012,
and 2022.\14\
---------------------------------------------------------------------------
\9\ See Letter from Office of Under Secretary of Defense to the
U.S. House of Representatives Committee on Appropriations (May 7,
2001), available on the rulemaking docket at www.regulations.gov
(hereinafter ``Defense Letter'').
\10\ U.S. Central Command. Area of Responsibility. https://www.centcom.mil/AREA-OF-RESPONSIBILITY/.
\11\ Department of Defense. Open Burn Pit Report to Congress.
2019. https://www.acq.osd.mil/eie/Downloads/Congress/Open%20Burn%20Pit%20Report-2019.pdf.
\12\ See Defense Letter, supra.
\13\ Center of Military History, United States Army. United
States Forces, Somalia After Action Report and Historical Overview:
The United States Army in Somalia, 1992-1994. https://www.history.army.mil/html/documents/somalia/.
\14\ CRS Report R42738, Instances of Use of United States Armed
Forces Abroad, 1798-2022, https://crsreports.congress.gov/product/pdf/R/R42738/38; Stimson Center, U.S. Security Assistance to
Somalia, https://www.stimson.org/2023/us-security-cooperation-with-somalia/.
---------------------------------------------------------------------------
Additionally, all the locations listed in 38 U.S.C. 1119(c) have
similar arid desert climate conditions. DoD's 2008 Enhanced Particulate
Matter Surveillance Program studied the chemical and physical
properties of dust at 15 deployment sites in the Middle East, Central
Asia, and Northeast Africa.\15\ The study found that Military Exposure
Guideline (MEG) values for PM2.5 were exceeded at all 15
sites for the entire one-year sampling period.\16\ The study also
demonstrated how short-term dust events--exacerbated by dirt roads,
agricultural activities, and disturbance of the desert floor by
motorized vehicles--all contribute to exceedance of both
PM10 and PM2.5 mass exposure guidelines and
standards.\17\ Finally, DoD's report also stated that PM2.5
levels in the Middle East are as much as ten times greater than the
levels at both urban and rural southwestern U.S. air monitoring
sites.\18\
---------------------------------------------------------------------------
\15\ Department of Defense. Enhanced Particulate Matter
Surveillance Program Final Report. 2008. https://apps.dtic.mil/sti/pdfs/ADA605600.pdf (hereinafter ``EPMSP Report'').
\16\ Id.
\17\ Id.
\18\ Id.
---------------------------------------------------------------------------
Dust storms and high windblown dust concentrations are one of many
environmental hazards experienced during deployment to locations within
U.S. Central Command. Windblown dust in these locations is considered
an airborne hazard because it combines with elemental carbon and metals
that arise from transportation and industrial activities.\19\ Although
dust in these locations can be toxic based on transportation and
industrial activities alone, open air burn pits increase the
concentration of toxins in PM2.5.
---------------------------------------------------------------------------
\19\ NASEM 2011 Report, supra.
---------------------------------------------------------------------------
As discussed above, in locations that rely on open burning of
waste, the PM2.5 air pollution in that location will contain
toxic combustion emissions. Open burning is the ``burning of any matter
in such a manner that products of combustion resulting from the burning
are emitted directly into the ambient or surrounding outside air
without passing through an adequate stack, duct or chimney.'' \20\ The
Environmental Protection Agency (EPA) defines ``ambient air'' as ``that
portion of the atmosphere, external to buildings, to which the general
public has access.'' 40 CFR 50.1(e). Because PM2.5 is a form
of ambient air pollution and open burning of waste emits toxic
combustion emissions into the ambient air, VA considers exposure to
PM2.5 as encompassing exposure to burn pit smoke.
---------------------------------------------------------------------------
\20\ Estrellan, C.R. and Iino, F. (2010) Toxic Emissions from
Open Burning. Chemosphere, 80, 193-207. https://doi.org/10.1016/j.chemosphere.2010.03.057.
---------------------------------------------------------------------------
The 38 U.S.C. 1119(c) locations have a history of annual
PM2.5 levels that exceed military and EPA air quality
standards. Not only do they exceed air quality standards, average
PM2.5 concentrations have been increasing in North Africa
and the Middle East since 1990, while Europe and North America have
experienced decreasing trends in average PM2.5
concentrations.\21\ Based on evidence of burn pit use, PM2.5
levels that exceed military and EPA air quality standards, and their
arid desert climate conditions that exacerbate PM2.5 levels,
VA finds there is sufficient evidence to extend the presumption of
exposure to PM2.5 beyond the locations listed in 38 CFR
3.320 to Egypt, Jordan, Lebanon, Somalia, and Yemen. Moreover, for
consistency with 38 U.S.C. 1119(c)(1)(B), which presumes toxic exposure
in certain countries (including Afghanistan, Syria, Djibouti, and
Uzbekistan) back to September 11, 2001, new 38 CFR 3.320a will have a
presumption of exposure for Veterans who served in those countries on
or after September 11, 2001.
---------------------------------------------------------------------------
\21\ EPMSP Report, supra.
---------------------------------------------------------------------------
VA notes that the PACT Act's definition of a ``covered Veteran'' in
38 U.S.C. 1119(c) does not include all areas historically included in
the Southwest Asia theater of operations, omitting the neutral zone
between Iraq and Saudi Arabia, the Gulf of Aden, the Gulf of Oman, the
Persian Gulf, the Arabian Sea, and the Red Sea. However, in this IFR,
VA shall maintain the locations currently included in the Southwest
Asia theater of operations under 38 CFR 3.317(e)(2) and 3.320(a)(6), as
that list was based on Executive Order 12744 of January 21, 1991, which
designated the combat zone of the Persian Gulf War. Doing so allows
individuals with service in those locations to still qualify as covered
veterans under 38 CFR 3.320a. VA will carry over the definition of
``Southwest Asia Theater of Operations'' from 38 CFR 3.317(e)(2) and
3.320(a)(6) into 38 CFR 3.320a.
b. Urinary Bladder, Ureter, and Related Cancers
The PACT Act presumption determination process consists of four
phases. The Ongoing Exploratory Surveillance Phase includes
collaborating with VA partners, to include Veterans Service
Organizations and other stakeholders, to identify, monitor, and
investigate potential toxic exposures and adverse health effects. 38
U.S.C. 1172(a). The Research and Assessment Phase involves collecting
information, evidence, and data regarding a particular toxic exposure
and adverse health effect, and potentially conducting a scientific
study and analysis of the data. 38 U.S.C. 1172(c). Based on the
findings, VA's Military Environment Exposures Sub-Council (MEESC) may
recommend that the Secretary initiate a formal evaluation of the issue.
38 U.S.C. 1172(d).
If the Secretary adopts that recommendation, the Formal Evaluation
Phase begins. 38 U.S.C. 1173. In this phase, a technical working group
is convened to conduct an evaluation of the evidence and research
collected in the prior phases, as well as claims data, to render a
conclusion on the strength of the evidence, and to provide a
recommendation to the Secretary with respect to a presumption. 38
U.S.C. 1173. If the Secretary decides to accept the recommendation, the
Rulemaking and Implementation Phase then begins. 38 U.S.C. 1174.
Here, after research and assessment, and at the MEESC's
recommendation, on February 26, 2024, the Secretary initiated a formal
evaluation of GU cancers and their possible association with exposure
to PM2.5 pollution in the Southwest Asia Theater of
Operations. In April 2024, the formal evaluation concluded and the
recommendation was to establish a presumption.\22\ On June 25, 2024,
the recommendation was conveyed to the Secretary. On October 25, 2024,
the Secretary accepted the
[[Page 26]]
recommendation, paving the way for this rulemaking.
---------------------------------------------------------------------------
\22\ The MEESC report (hereinafter MEESC Report) is attached to
this rulemaking, available at www.regulations.gov.
---------------------------------------------------------------------------
Under 38 U.S.C. 1173(b), a formal evaluation shall be based on the
review of available scientific literature, including human,
toxicological, animal, and methodological studies, and other factors,
and must consider claims data including claim rate, grant rate, and
service connection prevalence. It can also consider the level of
disability and mortality caused by the health effects related to the
case of toxic exposure being evaluated; the quantity and quality of the
information available and reviewed; the feasibility of and period for
generating relevant information and evidence; whether such health
effects are combat or deployment related; the ubiquity or rarity of the
health effects; and any time frame during which a health effect must
become manifest.
A formal evaluation shall review scientific evidence in a manner
that conforms to principles of scientific and data integrity; must be
free from suppression or distortion of scientific or technological
findings, data, information, conclusions, or technical results; must
evaluate the likelihood that a positive association exists between an
illness and a toxic exposure while serving in the active military,
naval, air, or space service; and determine whether the evidence
supports a finding of a positive association between the toxic exposure
and the illness. 38 U.S.C. 1173(c).
The Secretary had 160 days from June 25, 2024 (i.e., until December
2, 2024) to make a decision on the formal evaluation's recommendation.
38 U.S.C. 1174(a). The Secretary accepted the recommendation long
before the 160 days, on October 25, 2024, paving the way for this
rulemaking.
Throughout this process, the MEESC considered whether VA should
expand the PACT Act's existing organ-specific presumptions to organ-
system presumptions based on common embryologic development, proximity
to each other, and use of common structural pathways. For example,
kidney/renal cancers are covered under the PACT Act, as are all
reproductive organs. The MEESC considered whether it made sense from a
clinical and/or scientific standpoint to cover a significant portion of
the GU system (made up of the urinary and reproductive systems) but
exclude other organs within this same system.
As further discussed below, the GU system is composed of kidneys,
ureters, urinary bladder, urethra, reproductive, and genital organs.
The PACT Act provided a presumption for kidney/renal cancer and all
reproductive organ cancers for certain veterans; however, it did not
include ureteral, urinary bladder, and several related cancers of the
GU system. VA has determined it is necessary and clinically appropriate
to consider expanding presumptive status to cancers of these additional
organs for specific veteran populations. Clinical and scientific review
provides a strong scientific rationale to add the urinary bladder,
ureters, and associated structures.
The GU system as a whole encompasses the reproductive and urinary
system organs. These organs are usually grouped together because of a
common embryological origin, proximity to each other, and use of common
structural pathways.\23\ The GU system shares common embryologic,
anatomic, structural, and functional relationships through the
intermediate mesoderm, splanchnopleuric mesoderm, and the endoderm.\24\
---------------------------------------------------------------------------
\23\ Genitourinary System, Science Direct. https://www.sciencedirect.com/topics/medicine-and-dentistry/genitourinary-system.
\24\ Rehman S, Ahmed D, (Aug 8, 2023). Embryology, Kidney,
Bladder, and Ureter. StatPearls [internet]. https://www.ncbi.nlm.nih.gov/books/NBK547747/ (hereinafter ``Rehman'').
---------------------------------------------------------------------------
The urinary system's function is to filter blood and create urine
as a waste by-product. The organs of the urinary system include the
kidneys, renal pelvis, ureters, bladder, and urethra.\25\ The kidneys
and ureters form early in the embryotic period, after which the bladder
and urethra are formed.\26\ Week four of gestation commences with the
development of the urinary tract, which includes the kidney, ureter,
and urinary bladder. Bladder development is comprised of the
intermediate mesenchyme (embryonic connective tissue in the mesoderm)
and occurs when the urogenital septum divides.\27\ Once the bladder is
formed, it connects to the other organs. As the kidneys ascend, the
ureters elongate and open into the bladder superiorly, while the roots
of the mesonephric ducts are carried inferiorly, before fusing to form
the trigone region. Endodermal cells from the urogenital sinus soon
replace the mesodermal cells epithelium of the trigone region, thus
completing development.
---------------------------------------------------------------------------
\25\ Anatomy of the Urinary System. https://www.hopkinsmedicine.org/health/wellness-and-prevention/anatomy-of-the-urinary-system.
\26\ Kucharz, E.J. (1992). Urinary and Reproductive Systems. In:
The Collagens: Biochemistry and Pathophysiology. Springer, Berlin,
Heidelberg. https://doi.org/10.1007/978-3-642-76197-3_18.
\27\ Rehman, supra.
---------------------------------------------------------------------------
Between 32-36 weeks gestation, this development is completed and
the organs become distinct. The urachus, an embryonic remnant, connects
the bladder to the umbilical cord during fetal development and is the
main fetal excretory organ. After birth, this tube closes and becomes a
ligament, although it fails to close some cases.\28\
---------------------------------------------------------------------------
\28\ See MEESC memorandum, ``Additional Clarification and
Details on Genitourinary Cancer Formal Evaluation in Support of
Rulemaking'' dated November 6, 2024 (hereinafter MEESC Memorandum),
attached to this rulemaking, available at www.regulations.gov.
---------------------------------------------------------------------------
The kidney consists of various cell types originating from the
ureteric bud and the metanephrogenic mesenchyme, which differentiate
into more than 26 different cell types in the kidney. The ureteric bud
contributes to the development of the ureter and parts of the kidney,
which serves a critical role in the formation of the renal collecting
system.\29\ Embryologically, the urothelium of the urinary bladder and
urethra is derived from the ventral urogenital sinus, like the
epithelium in the renal pelvis and ureters.\30\ In utero, the
intermediate mesoderm forms the kidneys, ureters, and renal
vasculature. The splanchnopleuric mesoderm forms the smooth muscle and
connective tissue of the bladder. The endoderm forms the inner bladder
and urethra.\31\ The development of the ureter and kidney cells are
closely linked through the interaction of the ureteric bud and
metanephric mesenchyme, leading to the formation of the complex
structures of the urinary system.\32\ The urethra in the neck of the
bladder develops into the male urethra prostatic part, and female
urethra.\33\
---------------------------------------------------------------------------
\29\ Qais Al-Awqati; Juan A. Oliver, (February 2002). Stem Cells
in the Kidney. Kidney International, Volume 61, Issue 2. https://www.sciencedirect.com/science/article/pii/S0085253815482262?via%3Dihub.
\30\ Guo-Xia Tong, Woojin M Yu, Nike T Beaubier, et al.,
(September 2009) Expression of PAX8 in Normal and Neoplastic Renal
Tissues: An Immunohistochemical Study. Modern Pathology, Volume 22,
Issue 9, 1218-1227. https://www.sciencedirect.com/science/article/pii/S0893395222024747?via%3Dihub.
\31\ Rehman, supra.
\32\ Shah MM, Tee JB, Meyer T, Meyer-Schwesinger C, Choi Y,
Sweeney DE, Gallegos TF, Johkura K, Rosines E, Kouznetsova V, Rose
DW, Bush KT, Sakurai H, Nigam SK. The instructive role of
metanephric mesenchyme in ureteric bud patterning, sculpting, and
maturation and its potential ability to buffer ureteric bud
branching defects. Am J Physiol Renal Physiol. 2009
Nov;297(5):F1330-41. doi: 10.1152/ajprenal.00125.2009. Epub 2009 Sep
2. Erratum in: Am J Physiol Renal Physiol. 2010 May;298(5):F1285.
PMID: 19726549; PMCID: PMC2781331, https://pubmed.ncbi.nlm.nih.gov/19726549/.
\33\ Rehman, supra.
---------------------------------------------------------------------------
The organs of the GU system are necessarily interrelated. The
kidneys filter waste and fluid, including toxic exposures that get into
the body, to produce urine. Once the kidneys produce the urine, it is
transported from
[[Page 27]]
the kidneys to the urinary bladder by the ureters, which are bilateral
tubular structures that connect the kidneys to the urinary bladder. The
openings of the ureters into the urinary bladder are called the
ureteric orifices. The urine, which contains the waste that was
filtered from the body by the kidneys, is stored in the urinary bladder
until it is time to urinate. When it is time to urinate, the urethra, a
small tube, allows the urine to pass outside the body.
As discussed, the GU system cancers share common embryologic,
anatomic, structural, and functional relationships. Necessarily, each
of these organs is exposed to the waste/toxins, starting in the
kidneys, which is turned into urine. The urothelium is exposed to
toxins in the urine, so that any carcinogenic effect would also be
expected in the bladder and ureter. The urine exposes the remaining GU
structures to the toxins and any resultant carcinogens, including
PM2.5.\34\ Hence, any carcinogens in the kidneys or bladder
necessarily pass through the remainder of the GU system, providing the
exposure to carcinogens to each part of the GU system.
---------------------------------------------------------------------------
\34\ MEESC Report, supra.
---------------------------------------------------------------------------
1. Association Between PM2.5 and Urinary Bladder Cancer
In support of this rulemaking, as required by 38 U.S.C. 1173, VA
conducted a formal evaluation of whether a sufficient association
between PM2.5 and bladder cancer existed. The results of the
studies reviewed by VA's experts showed an association between
PM2.5 and bladder cancer and that 6-19% of bladder cancers
are attributable to occupational exposures. Studies from 2003 to 2022
supported the association between PM2.5 and bladder cancer.
A 2003 study estimated occupational exposure caused death due to
bladder cancer for 534 to 1,451 men and 116 to 740 women annually.\35\
Nine years later, the International Association for Research on Cancer
(IARC) also found evidence that air pollution was associated with
developing bladder cancer.\36\ In 2017, another study positively
correlated the concentration of ambient PM2.5 with
development of, and death from, bladder cancer.\37\ That same year a
study also found airborne pollution and particulate matter posed an
elevated risk for bladder cancer.\38\ Two 2020 studies similarly found
an elevated hazard ratio between exposure to air pollution and PM and
the development of bladder cancer, concluding such exposures may be a
risk factor for bladder cancer.\39\ According to a 2020 scientific
review of bladder and kidney cancer, studies suggested positive, even
though mostly non-significant, associations between air pollution
exposure, including PM2.5, and bladder cancer mortality and
kidney cancer incidence. Bladder cancer showed a positive association:
bladder cancer mortality had an adjusted odds-ratio of an average of
13% percent with a slight increase of PM2.5. r.\40\
---------------------------------------------------------------------------
\35\ Steenland K, Burnett C, Lalich, et al., (May, 2003). Dying
for work: The magnitude of US mortality from selected causes of
death associated with occupation. Am J Ind Med. 43(5):461-82.
https://pubmed.ncbi.nlm.nih.gov/12704620/.
\36\ IARC (International Association for Research on Cancer).
Air Pollution and Cancer, IARC Scientific Publication No. 161, 2013.
https://publications.iarc.fr/Book-And-Report-Series/Iarc-Scientific-Publications/Air-Pollution-And-Cancer-2013.
\37\ Yeh, H.L., Hsu, S.W., Chang, Y.C., Chan, T.C., Tsou, H.C.,
Chang, Y.C., & Chiang, P.H. (2017). Spatial Analysis of Ambient
PM2.5 Exposure and Bladder Cancer Mortality in Taiwan.
International journal of environmental research and public health,
14(5), 508; https://pmc.ncbi.nlm.nih.gov/articles/PMC5451959.
\38\ Turner MC, Krewski D, Diver WR, Pope CA 3rd, Burnett RT,
Jerrett M, Marshall JD, Gapstur SM. Ambient Air Pollution and Cancer
Mortality in the Cancer Prevention Study II. Environ Health
Perspect. 2017 Aug 21;125(8):087013; https://ehp.niehs.nih.gov/doi/10.1289/EHP1249.
\39\ Coleman NC, Burnett RT, Higbee JD, Lefler JS, Merrill RM,
Ezzati M, Marshall JD, Kim SY, Bechle M, Robinson AL, Pope CA 3rd.
Cancer mortality risk, fine particulate air pollution, and smoking
in a large, representative cohort of US adults. Cancer Causes
Control. 2020 Aug;31(8):767-776. (hereafter Cancer mortality risk);
https://pubmed.ncbi.nlm.nih.gov/32462559.
\40\ Zare Sakhvidi MJ, Lequy E, Goldberg M, Jacquemin B. Air
pollution exposure and bladder, kidney and urinary tract cancer
risk: A systematic review. Environ Pollut. 2020 Dec;267:115328;
https://www.sciencedirect.com/science/article/abs/pii/S0269749120360164?via%3Dihub.
---------------------------------------------------------------------------
The EPA also concluded that long-term exposure to PM2.5,
in the form of diesel exhaust emissions, has a likely causal
relationship to the development of bladder cancer.\41\ This is
supported by a 2022 EPA study.\42\ Supporting the previous studies, a
2022 large pooled study found evidence of an association between long-
term PM2.5 mass exposure and bladder cancer. A 2024 study
performed a meta-analysis which combined the results of from 18 cohort
studies, 10 case-control studies, and nine ecological studies, studies
published through early 2024. The authors stated that a 5 microgram
increase per cubic meter in the atmosphere in PM2.5 was
significantly associated with an increased relative risk for bladder
cancer of 7%.\43\
---------------------------------------------------------------------------
\41\ EPA Supplement to the 2019 Integrated Science Assessment
for Particulate Matter (Final Report, 2022) https://www.epa.gov/isa/integrated-science-assessment-isa-particulate-matter (hereafter
``EPA supplement'').
\42\ Id.
\43\ Li J, Deng Z, Soerensen SJC, Kachuri L, Cardenas A, Graff
RE, Leppert JT, Langston ME, Chung BI. Ambient air pollution and
urological cancer risk: A systematic review and meta-analysis of
epidemiological evidence. Nat Commun. 2024 Jun 15;15(1):5116,
https://pmc.ncbi.nlm.nih.gov/articles/PMC11180144/.
---------------------------------------------------------------------------
PM2.5 exposure is of concern for those deployed to the
Southwest Asia Theater of operations and other known BPOT locations. VA
has already examined studies by NASEM on the contribution of air
pollution to adverse health effects among U.S. Service members serving
in the Middle East.\44\ 86 FR at 42725-42726. Thus, VA has determined
that it will consider bladder cancers for this population to be
associated with exposure to PM2.5. Accordingly, VA concludes
it is appropriate to add bladder cancer to 38 CFR 3.320a.
---------------------------------------------------------------------------
\44\ NASEM, Gulf War and Health Series: Volume 3: Fuels and
Products of Combustion (2005), https://doi.org/10.17226/11180 and
Volume 11: Generational Health Effects of Serving in the Gulf War
(2018), https://doi.org/10.17226/25162. NASEM, Respiratory Health
Effects of Airborne Hazards Exposures in the Southwest Asia Theater
of Military Operations (2020), https://doi.org/10.17226/25837.
---------------------------------------------------------------------------
2. Association Between PM2.5 and Cancers of the Ureter,
Ureteric Orifice, Urachus, Over-Lapping and Sites of the Bladder
Ureter cancer is a rare type of cancer; however, between 5% and 10%
of all urothelial cancers start in the ureter.\45\ As discussed above,
all parts of the GU system share the same embryonic origin. The
development of ureter and kidney cells is closely linked through the
interaction of the ureteric bud and metanephric mesenchyme, leading to
the formation of the complex structures of the urinary system.
---------------------------------------------------------------------------
\45\ Saint John's Cancer Institute. Ureteral Cancer and Ureteral
Urothelial Carcinoma (UTUC).https://www.saintjohnscancer.org/urology/conditions/ureteral-cancer/.
---------------------------------------------------------------------------
The PACT Act has associated kidney cancer with PM2.5 for
certain Veterans. The kidneys transport waste into the ureters.\46\
From the ureters, the ureteric orifices empty the urine into the
urinary bladder. Each of these organs is exposed to waste and toxins
produced by the kidneys, thus exposing them to any carcinogens.\47\
Accordingly, the same PM2.5 that affected the kidneys
necessarily affects the entire GU tract. Because individuals with renal
pelvis or ureter cancer can develop cancer in the kidneys and/or
bladder over time,\48\ there are common risk factors for cancer
development throughout the uroepithelium. As such, VA concludes
[[Page 28]]
that bladder, ureter, and kidney cancers should all be treated the same
for purposes of the presumption.\49\
---------------------------------------------------------------------------
\46\ MEESC Memorandum, supra.
\47\ Id.
\48\ MEESC Report, supra.
\49\ Id.
---------------------------------------------------------------------------
III. Addition of Urinary Bladder, Ureter, and Related Cancers to 38 CFR
3.320a
Since August 5, 2021, VA has presumed for certain Veterans that
asthma, rhinitis, or sinusitis are associated with PM2.5. 38
CFR 3.320(a)(2); 86 FR at 42732-42733. VA added nine rare cancers to
the list of disabilities presumptively associated with PM2.5
on April 26, 2022. 38 CFR 3.320(a)(3); 87 FR 24421, 24429 (2022). VA
instituted these presumptions based on scientific and medical studies,
which focused on the respiratory effects of PM2.5 for
veterans who served in the Southwest Asia theater of operations,
Afghanistan, Syria, Djibouti, and Uzbekistan during the Gulf War. 86 FR
at 42729; 87 FR at 24424-24525.
As discussed above, in the PACT Act, Congress enacted a presumption
associating kidney cancer and reproductive cancers (which includes male
urethra and prostate cancer) with toxic exposures in covered locations.
38 U.S.C. 1120(b)(2)(E), (G). Although the PACT Act covers almost 73%
of existing cancers, it did not include all genitourinary tract
cancers.\50\ Yet Congress authorized VA to enact additional
presumptions based on a positive association with a substance,
chemical, or airborne hazard. 38 U.S.C. 1120(b)(15). Because urinary
bladder cancer is related to PM2.5 inhalation and BPOT
exposure, and cancers of the ureter and related cancers receive toxins
in the same manner as the bladder, VA concludes they should be extended
a presumption in new 38 CFR 3.320a.
---------------------------------------------------------------------------
\50\ MEESC Report, supra.
---------------------------------------------------------------------------
As discussed above, VA is enacting this presumption pursuant to the
38 U.S.C. 1171 et seq. process. But VA also notes the alternative
authority to add these presumptions under 38 U.S.C. 501(a)(1), which
permits VA to issue necessary or appropriate regulations with respect
to the nature and extent of proof and evidence in order to establish
rights to benefits, such as presumptions of service connection.
IV. New 38 CFR 3.320a
VA will use the heading of ``[p]resumptive service connection for
bladder, ureter, and related genitourinary cancers'' for 38 CFR 3.320a.
VA will describe the presumption of exposure in paragraph (a), describe
the presumptions of service connection in paragraph (b), provide the
definition of covered veteran in paragraph (c), and provide the
standard exceptions for presumptions in paragraph (d).
Although this rulemaking is based on current medical and scientific
evidence related to the respiratory health effects of PM2.5
on veterans who served during the Gulf War and are otherwise covered by
the PACT Act, VA will continue to review new scientific evidence as it
develops regarding all health effects resulting from exposure to BPOT,
including PM2.5. This rulemaking does not limit the future
establishment of additional presumptions of service connection.
V. Severability
The purpose of this section is to clarify the agency's intent with
respect to the severability of provisions of this rule. Each provision
of this rule is capable of operating independently. If any provision of
this rule is determined by judicial review or operation of law to be
invalid, that partial invalidation will not render the remainder of
this rulemaking invalid. Likewise, if the application of any portion of
this rule to a particular circumstance is determined to be invalid, the
agency intends that the rule remain applicable to all other
circumstances.
Administrative Procedure Act
Pursuant to 5 U.S.C. 553(b)(B) and (d)(3), VA has concluded that
there is good cause to publish the IFR without prior opportunity for
comment and to publish the rule with an immediate effective date. There
is good cause to immediately address the needs of Service members and
veterans who have been exposed to airborne hazards, i.e.,
PM2.5, due to their service in the Southwest Asia theater of
operations, Afghanistan, Syria, Djibouti, Uzbekistan, Somalia, Egypt,
Jordan, Lebanon, and Yemen.
VA concludes that the ordinary notice-and-comment procedures here
would be impracticable, in that they would cause Veterans serious harm
by further delaying and in some cases outright preventing Veterans from
receiving the benefits of these presumptions given the nature of the
diseases at issue. In particular, bladder and ureter cancers are
diseases of significant morbidity and mortality. Bladder cancer alone
is fairly common and causes morbidity and mortality. According to the
latest national statistics available from the Centers for Disease
Control and Prevention (CDC) which were from 2021, bladder cancer is
the seventh most common cancer in the U.S. with a rate of 18.1 cases
per 100.000 persons.\51\ In 2021, 75,450 new cases of urinary bladder
cancer were reported in the U.S.\52\ In 2022, which is the latest year
for which CDC has available mortality data, 17,334 people died of
urinary bladder cancer in the U.S. Most of the deaths were in men,
according to the CDC.\53\ In 2022, the latest year for which mortality
data are available, in the United States, 12,460 men died of urinary
cancer.\54\ For ureter cancer, the five-year survival rate is 5% or
less.\55\
---------------------------------------------------------------------------
\51\ United States Cancer Statistics: Data Visualizations,
https://gis.cdc.gov/Cancer/USCS/#/AtAGlance/.
\52\ Id.
\53\ Id.
\54\ Id.
\55\ Social Security Administration, Program Operations Manual
System, https://secure.ssa.gov/poms.nsf/lnx/0423022345.
---------------------------------------------------------------------------
Overall, delaying this rulemaking for notice and comment runs the
real risk of harming the very population this rulemaking intends to
help. Moreover, the 38 U.S.C. 1119(c) locations are dictated by
Congress; they cannot be removed by either VA or public comment.
The new presumptions are entirely pro-claimant in nature. They do
not adversely affect any person. And because VA has a sufficient
scientific basis to support the new presumptions, withholding the
presumptions during the notice and comment process could unnecessarily
deprive veterans and beneficiaries of benefits to which they would
otherwise be entitled and prolong their inability to timely receive
benefits. Additionally, this could create risks to beneficiaries'
welfare and health that would be exacerbated by any additional delay in
implementation. Due to the complexity and the historical scientific
uncertainty surrounding these issues of airborne hazard exposures and
disease, many veterans who will be affected by this rule have long
borne the burden and expense of their disabilities while awaiting the
results of research and investigation. Under these circumstances, there
is good cause to avoid further delay on their receipt of benefits,
potentially at the risk of their welfare and health.
Overall, the Secretary's decision to extend new presumptions to
veterans who have been exposed to PM2.5 due to their service
in the Southwest Asia theater of operations, and Somalia, Afghanistan,
Djibouti, Egypt, Jordan, Lebanon, Syria, Yemen, and Uzbekistan requires
immediate effect to help them access these benefits without undue
delay. For veterans that are not otherwise eligible for health care,
these presumptions could result in needed
[[Page 29]]
health care eligibility based on service connection.
Section 553(d) of 5 U.S.C. also requires a 30-day delayed effective
date following publication of a rule, except for ``(1) a substantive
rule which grants or recognizes an exemption or relieves a restriction,
(2) interpretative rules and statements of policy, or (3) as otherwise
provided by the agency for good cause found and published with the
rule.'' Pursuant to section 553(d)(3), the Secretary finds that there
is good cause to make the rule effective upon publication, for the
reasons discussed above.
For the foregoing reasons, and as explained in further detail in
the IFR, the Secretary of Veterans Affairs is issuing this rule as an
IFR with an immediate effective date. However, VA will consider and
address comments that are received within 60 days of the date this IFR
is published in the Federal Register.
Executive Orders 12866, 13563, and 14094
Executive Order 12866 (Regulatory Planning and Review) directs
agencies to assess the costs and benefits of available regulatory
alternatives and, when regulation is necessary, to select regulatory
approaches that maximize net benefits (including potential economic,
environmental, public health and safety effects, and other advantages;
distributive impacts; and equity). Executive Order 13563 (Improving
Regulation and Regulatory Review) emphasizes the importance of
quantifying both costs and benefits, reducing costs, harmonizing rules,
and promoting flexibility. Executive Order 14094 (Executive Order on
Modernizing Regulatory Review) supplements and reaffirms the
principles, structures, and definitions governing contemporary
regulatory review established in Executive Order 12866 of September 30,
1993 (Regulatory Planning and Review), and Executive Order 13563 of
January 18, 2011 (Improving Regulation and Regulatory Review). The
Office of Information and Regulatory Affairs has determined that this
rulemaking is a significant regulatory action under Executive Order
12866, Section 3(f)(1), as amended by Executive Order 14094. The
Regulatory Impact Analysis associated with this rulemaking can be found
as a supporting document at www.regulations.gov.
Unfunded Mandates
The Unfunded Mandates Reform Act of 1995 requires, at 2 U.S.C.
1532, that agencies prepare an assessment of anticipated costs and
benefits before issuing any rule that may result in the expenditure by
state, local, and tribal governments, in the aggregate, or by the
private sector, of $100 million or more (adjusted annually for
inflation) in any one year. This IFR will have no such effect on state,
local, and tribal governments, or on the private sector.
Paperwork Reduction Act
Although this interim final rule contains provisions constituting
collection of information under the provisions of the Paperwork
Reduction Act of 1995 (44 U.S.C. 3501-3521), there are no provisions
associated with this rulemaking constituting any new collection of
information or any revisions to the existing collection of information.
The collection of information for 38 CFR 3.320a is currently approved
by the Office of Management and Budget (OMB) and has been assigned OMB
control numbers 2900-0747, 2900-0886, 2900-0004, and 2900-0002.
Congressional Review Act
Under the Congressional Review Act, this regulatory action may
result in an annual effect on the economy of $100 million or more, 5
U.S.C. 804(2), and so is subject to the 60-day delay in effective date
under 5 U.S.C. 801(a)(3). In accordance with 5 U.S.C. 801(a)(1), VA
will submit to the Comptroller General and to Congress a copy of this
Regulation and the Regulatory Impact Analysis (RIA) associated with the
Regulation.
List of Subjects in 38 CFR Part 3
Administrative practice and procedure, Claims, Disability benefits,
Health care, Pensions, Veterans.
Signing Authority
Denis McDonough, Secretary of Veterans Affairs, signed and approved
this document on December 20, 2024, and authorized the undersigned to
sign and submit the document to the Office of the Federal Register for
publication electronically as an official document of the Department of
Veterans Affairs.
Michael P. Shores,
Director, Office of Regulation Policy & Management, Office of General
Counsel, Department of Veterans Affairs.
For the reasons stated in the preamble, the Department of Veterans
Affairs amends 38 CFR part 3 as set forth below:
PART 3--ADJUDICATION
Subpart A--Pension, Compensation, and Dependency and Indemnity
Compensation
0
1. The authority citation for part 3 continues to read as follows:
Authority: 38 U.S.C. 501(a), unless otherwise noted.
0
2. Add Sec. 3.320a to read as follows:
Sec. 3.320a Presumptive service connection for bladder, ureter, and
related genitourinary cancers.
(a) Presumption of exposure. A covered veteran as defined in
paragraph (c) of this section shall be presumed to have been exposed to
certain toxic substances, chemicals, and airborne hazards, including
fine particulate matter, during such service, unless there is
affirmative evidence to establish that the veteran was not exposed to
any such toxic substances, chemicals, and airborne hazards during that
service.
(b) Presumption of service connection. Except as provided in
paragraph (d) of this section, the following diseases becoming manifest
in a covered veteran, as defined in paragraph (c) of this section,
shall be considered to have been incurred in or aggravated during
active military, naval, air, or space service, notwithstanding that
there is no record of evidence of such disease during the period of
such service:
(1) Urinary bladder cancer, including over-lapping sites of the
bladder.
(2) Ureter cancer, including the ureteric orifice, and urachus.
(c) Covered Veteran. For purposes of this section, the term covered
veteran means any veteran who:
(1) On or after August 2, 1990, performed active military, naval,
air, or space service while assigned to a duty station in, including
airspace above
(i) The Southwest Asia theater of operations as defined in Sec.
3.317(e)(2); or
(ii) Somalia; or
(2) On or after September 11, 2001, performed active military,
naval, air, or space service while assigned to a duty station in,
including airspace above:
(i) Afghanistan;
(ii) Djibouti;
(iii) Egypt;
(iv) Jordan;
(v) Lebanon;
(vi) Syria;
(vii) Yemen; or
(viii) Uzbekistan.
(d) Exceptions. A disease listed in paragraph (b) of this section
shall not be presumed service connected if there is affirmative
evidence that:
(1) The disease was not incurred or aggravated during active
military, naval, air, or space service; or
[[Page 30]]
(2) The disease was caused by a supervening condition or event that
occurred between the Veteran's most recent departure from active
military, naval, air, or space service and the onset of the disease; or
(3) The disease is the result of the Veteran's own willful
misconduct.
(Authority: 38 U.S.C. 501, 1119, 1120, 1174)
[FR Doc. 2024-31220 Filed 12-31-24; 8:45 am]
BILLING CODE 8320-01-P